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ABSTRACT 
The overall purpose of the current thesis was to evaluate the influence of various 
exercise strategies on Parkinson's disease (PD). While countless exercise interventions 
have been investigated in PD, results have been weak and inconclusive at best. As such, 
there are currently no scientifically-validated recommendations for an optimal exercise 
intervention. The four studies comprising this thesis have attempted to address the 
shortcomings of previous literature, namely, inconsistent use of outcome measures, lack 
of PD symptomatic measures, varying lengths of exercise interventions, absence of a 
non-exercise control group, continued assessment of participants after exercise has ended, 
and verifying replicability of findings. 
The first study was focused on identifying objective outcome measures that are 
predictive or reflective of the classic symptoms associated with PD. Symptomatic 
assessment was conducted using the Unified Parkinson's disease Rating Scale (UPDRS), 
the current gold standard for assessment of PD symptom severity. Objective outcome 
measures included the timed-up-and-go (TUG), grooved pegboard (GP), and 
spatiotemporal aspects of self-paced gait (velocity, step length). Backward elimination 
regression analysis demonstrated that the place phase of the GP was the most predictive 
of UPDRS score. Interestingly, no objective outcome measures were strongly correlated 
with change on the symptomatic subsets that they were believed to be theoretically 
evaluating. The results point to the continued need to identify objective outcome 
measures reflective of symptomatic assessment. Further, exercise rehabilitation trials 
should combine outcome measures with symptomatic assessment to ensure that 
improvements are reflective of symptomatic improvement. 
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The second study compared the influence of four exercise interventions (in 
contrast to a non-exercising control group) on the symptoms of PD. The exercise 
interventions included aquatic exercise, aerobic training, strength training and sensory 
attention focused exercise (PD SAFEX). Each participant exercised three times per week 
for a twelve week period and the same trained evaluator (blinded to group assignment) 
performed symptomatic assessment of all participants before exercise began (pre-test) 
after exercise ended (post-test) and following a minimum six week non-exercise period 
(washout). Results displayed that the strength training and PD SAFEX interventions had 
the greatest symptomatic benefit from pre-test to post-test. The aerobic intervention had 
no apparent change to symptom severity across all three testing periods. Overall, the 
current study suggests that PD SAFEX and strength training are more beneficial for 
individuals with PD than aerobic or aquatic exercise. 
The third study attempted to determine the influence of increased focus on 
sensory feedback by comparing two identical exercise interventions that differed only in 
the presence (PD SAFEX) or absence (non-SAFE) of increased attention on sensory 
(specifically proprioceptive) feedback. Symptomatic assessment was combined with 
objective outcome measures that assessed upper limb motor control, functional gait and 
spatiotemporal aspects of self-paced gait. Findings suggested that both exercise 
interventions resulted in similar benefits on the objective outcome measures, including 
upper limb motor control (assessed using the grooved pegboard), functional gait 
(assessed using the timed-up-and-go) and velocity and step length of self-paced gait. 
Interestingly, only the PD SAFEX intervention resulted in improved PD symptoms 
assessed using the UPDRS and symptomatic improvement was maintained after a six 
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week non-exercise period. Thus, the increased focus on sensory feedback present in the 
PD SAFEX intervention appears to have an important additional influence on the 
symptoms of PD. 
The final study assessed whether improved PD symptoms following a sensory 
attention focused exercise (PD SAFEX) intervention could be replicated across multiple 
administrations and secondly, whether the effect could be replicated when administered 
by minimally trained individuals in the community. The PD SAFEX intervention was 
administered to four separate groups at the Movement Disorders Research and 
Rehabilitation Centre (MDRC) and twice at an exercise facility in the community 
(YMCA). Over the six administrations of the PD SAFEX intervention, similar 
symptomatic improvements were realized by participants. Interestingly, the community 
based intervention appeared to gain a greater symptomatic benefit than the PD SAFEX 
intervention administered by leaders knowledgeable in movement disorders and the 
underlying neurological deficits focused on in the PD SAFEX intervention. The 
consistency of the results displayed that symptomatic improvement following the PD 
SAFEX intervention was not due to chance but attributable to the exercise. The ability of 
the community based intervention to effectively administer the PD SAFEX intervention 
suggests that the feasibility of global distribution of the PD SAFEX intervention would be 
a logical direction for future research. 
The methodological improvements employed in the current thesis allowed for 
detailed and thorough comparisons to be drawn between various exercise interventions. It 
has been shown that strength training and PD SAFEX interventions have the greatest 
symptomatic benefit for individuals with PD. Further, the beneficial effect of increased 
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focus on sensory feedback and the simplicity of application of the PD SAFEX intervention 
suggest that the PD SAFEX intervention should be further explored for its ability to be 
globally implemented. 
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CHAPTER 1 
INTRODUCTION 
Parkinson's disease and its Neuroanatomical Correlates 
Parkinson's disease (PD) is one of the most prevalent movement disorders 
(Johnson & Almeida, 2007) caused by a degeneration of dopamine producing neurons in 
the basal ganglia (Wolters & Francot, 1998). The hallmark symptoms of PD include 
tremor, rigidity, bradykinesia (a slowness of movement), akinesia (overall absence of 
movement), and postural instability (Guttman, Kish, & Furukawa, 2003). Secondary 
impairments in PD include disturbance of the spatiotemporal aspects of gait such as step 
length and cadence (Morris, Iansek, Matyas, & Summers, 1994); cognitive impairments; 
micrographia (small writing); decreased speech volume; sleep disorders; and mood 
fluctuations (Guttman et al., 2003; Leung & Mok, 2005; Wolters & Francot, 1998). 
Unfortunately, the symptoms of PD only become visibly apparent after an estimated 60% 
of the available dopamine has been lost (Wolters & Francot, 1998) and neural pathways 
through the basal ganglia have been severely impaired. 
The basal ganglia refers to the caudate nucleus, putamen, globus pallidus (internal 
and external), subthalamic nucleus, and substantia nigra (Nolte, 2002). In PD, there is a 
pronounced degeneration of dopamine producing neurons in the substantia nigra, pars 
compacta, leading to a loss of dopamine in the striatum (Wolters & Francot, 1998). The 
loss of dopamine in the striatum affects two pathways through the basal ganglia to the 
thalamus that facilitate cortical output. 
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The direct pathway begins with input from the cortex to the striatum, which then 
sends an inhibitory signal to the globus pallidus internal. The output from the globus 
pallidus internal to the thalamus is subsequently decreased, however, as the role of the 
globus pallidus internal is to inhibit the output of the thalamus, decreased globus pallidus 
internal - thalamus input results in increased thalamus - cerebral cortex output. In PD, a 
lack of dopamine in the striatum, inhibits the direct pathway leading to decreased 
striatum output, increased globus pallidus output, and ultimately decreased thalamus 
output. The decreased thalamus output leads to diminished cortical activity, and is likely 
the root cause of characteristic symptoms of PD including bradykinesia and hypometria 
(small movements) (Nolte, 2002). 
An indirect pathway also passes through the basal ganglia to affect cortical 
output. The striatum sends an inhibitory signal to the globus pallidus external, decreasing 
output from the globus pallidus external to the subthalamic nucleus. The globus pallidus 
external is also inhibitory, thus a decreased output from the globus pallidus external leads 
to increased output from the subthalamic nucleus to the globus pallidus internal. The 
subthalamic nucleus is excitatory, and it increases the output from the globus pallidus 
internal to the thalamus. As the globus pallidus internal inhibits the thalamus, increased 
output from the globus pallidus internal results in decreased output from the thalamus. In 
PD, the lack of dopamine increases the activity of the indirect pathway, ultimately 
leading to decreased thalamus output and diminished cortical activity (Nolte, 2002). 
The end stage of both pathways is thalamus - cerebral cortex projections which 
are excitatory. In PD, the thalamus is inhibited by disruption in both pathways causing 
diminished cortical output which could be the underlying cause of the small, slow 
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movements observed in PD (Nolte, 2002; Wolters & Francot, 1998). As such, therapeutic 
interventions have been aimed at identifying chemical messengers or neurotransmitters 
that improve transmission along these pathways to restore proper thalamus - cerebral 
cortex output. 
The most common treatment for PD has revolved around pharmacotherapy to aid 
the disrupted dopamine system in the basal ganglia. The main medications used in the 
management of PD are levodopa (L-dopa), dopamine agonists, and monoamine oxidase 
(MAO) inhibitors. L-dopa is the most common medication and is a dopamine precursor 
which is metabolized in the periphery by dopa-decarboxylase (Leung & Mok, 2005). 
Dopamine agonists are used to stimulate dopamine receptors which increase the 
responsiveness of the neurons in the basal ganglia to the available dopamine. MAO 
inhibitors are used to reduce dopamine metabolism in the brain, thus maintaining 
dopamine levels (Guttman et al., 2003). The goal of utilizing medication to manage PD is 
to prescribe the smallest dosage that allows the patient to continue doing the activities 
that are important to them (Guttman et al., 2003). 
Small dosages are prescribed, especially in the early stages of PD as a number of 
motor (dyskinesia) and non-motor (nausea, hallucinations, sleep disorders) side effects 
can result from extended pharmacotherapy. The motor side effects generally begin with a 
wearing off of L-dopa medication, as the motor symptoms become more pronounced near 
the end of the medication cycle before the next dosage is administered. To combat 
wearing off of L-dopa, additional medications may be administered or L-dopa dosage 
may be increased. As pharmacotherapy continues, dyskinesias (involuntary, jerky, dance-
like movements of the head and arms) may become present (Guttman et al., 2003; Leung 
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& Mok, 2005). While the medications are beneficial in the short term, none of these 
therapies have proven to be neuroprotective or to delay the progression of Parkinson's 
disease (Guttman et al., 2003). Thus, once a patient begins using medication to treat PD, 
they will gradually increase their dose and reliance on medication to function optimally. 
Since, reliance on medication alone may not be the optimal strategy for 
management of PD, non-pharmacological treatments are of increasing importance and 
have been suggested to lead to lower therapeutic levels of dopaminergic medications 
needed, thereby improving the long-term prognosis (Johnson & Almeida, 2007). While 
effective management of PD will likely always involve some level of medication, the 
longer a patient can wait before beginning medication and the smaller the dosage needed 
to maintain optimum functioning, the better for the patient. 
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Exercise and the PD brain 
Physical exercise may not be an obvious choice of adjunct therapy for a 
neurological condition; however, animal models have demonstrated that exercise has the 
potential to positively affect brain plasticity and dopamine production. Following 
exercise, rats have been shown to increase serum calcium levels, which are transported to 
the brain, leading to an increase in dopamine production through a calmodulin-dependent 
system (Sutoo & Akiyama, 2003). Other animal models have evaluated the notion that 
exercise may potentiate the intrinsic plasticity of the brain by increasing expression of 
neurotrophic factors such as Brain Derived Neurotrophic Factor (BDNF). BDNF 
increases the activity of Synapsin I, which aids in the proper release of neurotransmitters 
at the synapse and in the development of new synapses (i.e. new pathways through the 
central nervous system) (Vaynman & Gomez-Pinilla, 2005). BDNF specifically, has been 
shown to be up-regulated by exercise and thus, exercise may benefit those with PD by 
increasing the activity of BDNF and Synapsin I which may aid in proper transmission 
across dopamine depleted synapses in the basal ganglia, or through the development of 
new neural pathways to aid or avoid the damaged basal ganglia. These animal models 
provide biological plausibility for the use of exercise as a specific treatment for PD. 
Parkinson's disease specific animal models, however, have been contradictory 
regarding the benefit of exercise on PD, with the main difference being the stage of 
disease progression. A study of early exercise intervention by Tillerson et al. using both 
rat and mice models of PD found that exercise was beneficial. Specifically, significant 
sparing of striatal dopamine, its metabolites, tyrosine hydroxylase, vesicular monoamine 
transporter, and dopamine transporter levels were found in animals that ran on a treadmill 
5 
compared to PD induced sedentary animals (Tillerson, Caudle, Reveron, & Miller, 2003). 
It is important to note that the animals in this study began exercising twelve hours after 
being induced with PD, and were considered mild severity PD. Another study by Al-
Jarrah et al. used mice that had been induced with chronic PD. This was done by injecting 
l-methyl-4-phenyl-l,2,3,6-tetrahydropyridine (MPTP) ten times over a period of five 
weeks; which is an excessive dosage as normally MPTP is only injected once in order to 
induce PD in mice. The chronic PD mice were able to gain all of the cardiorespiratory 
benefits (decreased heart rate, increased VO2, etc) of exercise but had no change in 
striatal dopamine, or its metabolites (Al-Jarrah et al., 2007). These studies raise the idea 
that there may be a certain period of neural deterioration in PD beyond which exercise 
will no longer affect brain plasticity or dopamine production. Further, the animal models 
are intriguing starting points as they provide information from invasive measurement but 
they do not necessarily reflect the effect of exercise on the human brain. 
Animal models suggest biological plausibility of the potential effect of exercise 
on the PD brain. Exercise may help reduce reliance on current pharmacotherapy (and 
avoid the associated side effects) through improved functioning of the direct and indirect 
pathways through the basal ganglia affecting thalamus - cortical output. Thus, 
investigating the effect of exercise as an adjunct therapy for PD is warranted. 
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The Need to Identify Appropriate Outcome Measures for PD Interventions 
The use of exercise as an alternative therapy in the management of PD has a fairly 
extensive history. However, no acceptable, scientifically validated guidelines for exercise 
are currently available (de Goede, Keus, Kwakkel, & Wagenaar, 2001; Deane et al., 
2002). One of the reasons for the lack of conclusion regarding exercise in PD has been 
the inconsistent use of appropriate outcome measures and a lack of symptomatic 
measures relevant to PD. 
The most important aspect of any PD rehabilitation strategy is the improvement of 
PD symptoms. While elements such as gait and mobility are impaired in PD and should 
be a focus of exercise rehabilitation, a literature review determined that mobility can be 
more easily influenced by physical therapy than neurological symptoms can (de Goede et 
al., 2001). This brings into question previous exercise rehabilitation research that has 
only used gait and mobility outcome measures and not included a PD symptomatic 
measure (Caglar, Gurses, Mutluay, & Kiziltan, 2005; Cakit, Saracoglu, Gene, Erdem, & 
Inan, 2007; del Olmo, Arias, Furio, Pozo, & Cudeiro, 2006; del Olmo & Cudeiro, 2005; 
Li et al , 2007; Lokk, 2000; Sunvisson, Lokk, Ericson, Winblad, & Ekman, 1997; Thaut 
et al., 1996; Viliani et al., 1999). Without combined improvement in both mobility and 
PD specific clinical measures it cannot be determined whether the exercise program was 
beneficial for the specific neurological deficits in PD or simply beneficial in a general 
cardiorespiratory and musculoskeletal sense. Essentially, clinical measures of PD 
symptoms are a critical component to PD exercise rehabilitation research to determine if 
the exercise is in fact beneficial in a disease specific manner. 
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The Unified Parkinson's Disease Rating Scale (UPDRS) (Fahn, 1987), may be the 
best option to address the identified lack of PD symptomatic measures in exercise 
rehabilitation trials. The UPDRS is the current gold standard for clinical assessment of 
Parkinson's symptoms and is used to detect symptomatic changes when approving new 
medications. PD symptoms are assessed individually using a five point scale with zero 
representing no symptoms present and four representing the most severe symptoms. The 
UPDRS is split into three major sections to assess mentation, behavior and mood, 
activities of daily living, and motor symptoms. Consistent use of a standardized measure 
of PD symptoms, such as the UPDRS, would allow for effective comparison between 
exercise interventions. 
Additionally, a lack of symptomatic measure is concerning as it has been 
increasingly recognized that improvement in a specific impairment such as step length, 
which is easily altered and measured, may have little benefit for the patient in their life 
(Deane et al., 2002). Further, the most consistently used measures in PD literature have 
been spatiotemporal aspects of gait, primarily step length, cadence and velocity. 
Although commonly utilized rarely do two studies measure these variables in the same 
manner. Self-paced gait has been measured over a number of distances including 4 m 
(Thaut et al., 1996), 10 m (Miyai et al., 2000; Miyai et al., 2002; Nieuwboer et al., 2007), 
20 m (Caglar et al., 2005) and 30 m (del Olmo et al., 2006; del Olmo & Cudeiro, 2005). 
Some researchers have used a treadmill to determine comfortable walking speed (Ellis et 
al., 2005), which limits the applicability to a real-world setting. Of note, other studies 
where the exercise was hikes in the mountains, with a focus on increasing mobility, no 
measure of gait was used (Lokk, 2000; Sunvisson et al., 1997). Some researchers have 
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attempted to analyze gait under various conditions including walking over uneven 
surfaces such as up a ramp and down a step (Thaut et al., 1996) or around obstacles 
(Brichetto, Pelosin, Marchese, & Abbruzzese, 2006), while performing secondary tasks 
such as turning the head (Cakit et al., 2007), or various reproduction tasks such as 
matching pace with a metronome (del Olmo & Cudeiro, 2005). The different conditions 
used to measure spatiotemporal aspects of gait make it difficult to compare changes and 
the changes may not be reflective of symptomatic improvement in PD. 
One interesting and potentially beneficial measure of gait may be to analyze 
changes in variability as PD results in variable movements especially surrounding aspects 
of gait such as step length (Hausdorff, Cudkowicz, Firtion, Wei, & Goldberger, 1998). 
Conceivably, if an exercise intervention has improved PD symptoms, then step to step 
variability would be reduced. Some research has found a decrease in gait variability such 
that following exercise individuals with PD were no longer significantly different than 
healthy height matched controls (del Olmo et al., 2006; del Olmo & Cudeiro, 2005). 
Improvements in gait variability, indicated by a stable and consistent gait pattern, may be 
more beneficial measures as they may represent improved neurological functioning 
relating to gait sequences including movement initiation, amplitude and dynamic balance 
control. 
Goal-directed mobility tasks have also been used in the literature with the most 
prominent test being the Timed-up-and-go (TUG). Tasks such as the TUG are considered 
functional tasks that mirror everyday activities. The TUG involves rising from a chair, 
walking 3 meters, returning to the chair and sitting down, which represent specific 
deficits in PD such as sit-to-stand, movement initiation and dynamic balance while 
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turning. Further, goal-directed tasks may require a conscious control of movement and 
are potentially a superior measure of changes to neural function than self-paced gait. 
Other, non-standardized functional tests that have been used include transfers and 
sit-to-stand movements (Viliani et al., 1999), a posturo-locomotor-manual task where an 
object is picked up and carried a distance (Sunvisson et al., 1997), and walking around a 
chair (Caglar et al., 2005). Similarly, numerous mobility measures have been attempted 
to assess functional changes such as the functional reach test (Li et al., 2007) and the 
Berg Balance Test (Cakit et al., 2007). The majority of these measures have not been 
used consistently and further complicate comparison between studies. 
Other deficits in PD such as bradykinesia and fine motor control have been even 
less consistently measured. Bradykinesia is measured as a portion of the overall UPDRS, 
however a specific bradykinesia outcome is not provided. The UPDRS motor section 
does have the ability to be broken down into its components to look at specific 
impairments. Marchese et al. separated midline bradykinesia (items 18, 19, 27, 30, and 
31) and limb bradykinesia (items 23-26) in an attempt to measure bradykinesia more 
effectively (Marchese, Diverio, Zucchi, Lentino, & Abbruzzese, 2000). Others have used 
timed movement sequences as a measure of bradykinesia (Sunvisson et al., 1997; Tamir, 
Dickstein, & Huberman, 2007). However, the majority of researchers do not use separate 
measures to specifically examine bradykinesia, which is surprising considering it is one 
of the cardinal symptoms of PD. 
Another aspect of PD that is not consistently measured is fine visuomotor control. 
Changes in fine motor control are not often assessed in PD literature as the focus is 
primarily mobility (Johnson & Almeida, 2007). However, fine motor control is integral in 
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the maintenance of independence as it is involved in tasks such as tying shoes, doing up 
buttons, and cutting food. Fine motor control is an important measure in PD as 
individuals with PD have been shown to have a dysfunction in sequential movements 
such as reaching for a glass and taking a drink (Bennett, Marchetti, Iovine, & Castiello, 
1995). The limited studies that have measured fine motor control have used the Purdue 
Pegboard (Craig, Svircev, Haber, & Juncos, 2006; Reuter, Engelhardt, Stecker, & Baas, 
1999) or a Nine Hole Peg Board (Caglar et al., 2005). Outcome measures assessing fine 
motor control would be beneficial as they are another identified deficit in PD and 
assessing the effect exercise has on a wide range of PD deficits allows a more complete 
conclusion to be reached. 
The inconsistent use and absence of symptomatic outcome measures in PD 
exercise rehabilitation literature makes comparison between interventions difficult and 
points to the need for standardized measures to be used across all exercise studies in PD. 
To address this shortcoming one important aim of the current thesis is to evaluate which 
objective measures represent symptomatic assessment with the UPDRS. 
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Parkinson's disease and Exercise Rehabilitation 
Previous exercise rehabilitation research has been inconclusive, and thus unable 
to provide recommendations for exercise and PD (de Goede et al., 2001; Deane et al., 
2002), but this has not been through a lack of trying. Exercise interventions that have 
been evaluated can be generally grouped into aerobic, strength/regular physical therapy 
practices, and sensory techniques. 
Aerobic interventions have been aimed at increasing mobility and aerobic 
capacity and usually used a form of walking as training. Walking inside and outside 
(Ashburn et al., 2007), mountain hiking (Lokk, 2000; Sunvisson et al., 1997), treadmill 
training (Bergen et al., 2002; Cakit et al., 2007; Herman, Giladi, Gruendlinger, & 
Hausdorff, 2007; Pohl, Rockstroh, Ruckriem, Mrass, & Mehrholz, 2003), body weight 
supported treadmill training (Miyai et al., 2000; Miyai et al., 2002) and cycle ergometry 
(Bergen et al., 2002; Burini et al., 2006) have all been attempted with PD populations. 
While aerobic interventions are likely beneficial for cardiorespiratory fitness, their 
effect on PD symptoms is less clear. For example, Miyai et al. used body-weight 
supported treadmill training (BWSTT) in two studies to determine its effects relative to 
regular physical therapy. The identical interventions found conflicting results in regard to 
PD symptoms. The first study found a significantly greater improvement on the UPDRS, 
specifically the ADL and motor sections, in BWSTT over regular physical therapy 
(Miyai et al., 2000). Conversely, the second study found no significant differences in the 
UPDRS following either BWSTT or physical therapy (Miyai et a l , 2002). These 
conflicting results, regarding aerobic training using the same intervention, point to the 
need for more work to be done in the area of aerobic training and PD. Further, it is worth 
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noting that aerobic interventions involving walking have generally resulted in 
improvements in spatiotemporal aspects of gait, specifically velocity and step length, 
while the effect on clinical PD symptoms has not been measured consistently and is less 
clear. 
The second grouping of exercise interventions falls under strength training and 
physical therapy practices. The aim of these interventions is generally to increase 
mobility, strength, range of motion and balance to assist with activities of daily living. 
These interventions have been done under numerous conditions including group or 
individual settings at the home, gym, and pool. Again, conflicting results have been 
found in relation to neurological symptoms, measured using the UPDRS, as some studies 
found positive results (Reuter et al., 1999), some found no significant improvement 
(Brichetto et al., 2006; Ellis et a l , 2005) and others did not measure PD symptoms 
(Caglar et al., 2005; Viliani et al , 1999). Conflicting results concerning the effect of a 
strengthening program are troubling considering the majority of these interventions were 
based on current physical therapy practices for the treatment of PD. 
Whole body strength training interventions have been studied even less frequently 
than physical therapy interventions. Two studies have been identified that utilized 
resistance exercises similar to a whole body program an individual might undergo at a 
fitness facility (Hass, Collins, & Juncos, 2007; Hirsch, Toole, Maitland, & Rider, 2003). 
One study measured PD symptoms with the UPDRS but found no significant difference 
after training (Hass et al., 2007). The second study found improved muscle strength and 
balance tests but had no PD symptomatic measure (Hirsch et al., 2003). Currently, there 
is an insufficient amount of research in the area of strength training to draw any 
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conclusions as to their efficacy; however, well designed research utilizing clinical 
measures of PD symptoms may be able to determine if strength training is an effective 
strategy for individuals with PD. 
The third exercise rehabilitation strategy, which is also one of the most promising 
avenues of neurological rehabilitation research involves the use of sensory enhancement 
to cue movement (Johnson & Almeida, 2007). The use of external cues to overcome 
deficits in gait has been well documented and it has been shown that auditory and visual 
cues can improve the disturbed gait present in PD (Lewis, Byblow, & Walt, 2000; 
Morris, Iansek, Matyas, & Summers, 1996; Rubinstein, Giladi, & Hausdorff, 2002). For 
example, if transverse lines are placed on the ground at distances equal to height matched 
controls, individuals with PD are able to improve their step length, cadence and velocity 
(Morris et al., 1996). Auditory cues have also been used in the form of a metronome 
paced faster than a patient's comfortable cadence and shown improvements in cadence, 
velocity and stride length among individuals with PD (Rubinstein et al., 2002). The 
external cues have been suggested to assist individuals with PD to overcome basal 
ganglia deficits. One hypothesized role of the basal ganglia is the selection of the 
appropriate motor set to complete a movement (Rubinstein et al., 2002). Thus, visual 
cues have been proposed to focus a participant's attention on gait and invoke a cortical 
control of movement, bypassing the dysfunctional basal ganglia and allowing for the 
proper motor set to be selected and carried out (Morris et al., 1996). A second 
hypothesized role of the basal ganglia is the internal regulation of submovements of a 
motor set to ensure the proper activation and deactivation of the appropriate areas of the 
supplementary motor area to carry out smooth movement during sequential movements 
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such as gait (Rubinstein et al., 2002). Perhaps, auditory cues are beneficial as they 
provide external cues that replace the dysfunctional signals from the basal ganglia. The 
exact mechanism behind the benefits observed through external cueing is less important 
than the fact that cues have shown visible improvements in PD gait. 
Numerous studies have attempted to apply the concepts of external cueing to 
exercise to determine if the short-term benefits observed in the laboratory will enhance 
the benefits of physical therapy (Brichetto et al., 2006; Marchese et al., 2000; Nieuwboer 
et al., 2007) or mobility training (del Olmo et al., 2006; del Olmo & Cudeiro, 2005; 
Thaut et al., 1996). Similar to more traditional forms of exercise, results from cueing 
strategies have been mixed. However, there is promise as demonstrated by Marchese et 
al. who followed two groups that completed identical exercise interventions except for 
the presence or absence of sensory cues. While they found both groups had a significant 
improvement in their UPDRS scores, of greater interest was that the cued group 
maintained their benefits six weeks following the end of the exercise program, while the 
beneficial effects had disappeared in the non-cued group (Marchese et al., 2000). These 
findings were suggested to display that sensory cueing invokes neurological changes that 
last longer than musculoskeletal changes resulting from traditional forms of exercise. 
Further benefits of mobility training using cues have been found; however, the 
studies did not use a clinical symptom measure such as the UPDRS as an outcome 
measure. These interventions did use other measures that suggested the interventions 
were improving neurological function. One group analyzed movement variability and 
found that following four weeks of exercise paced by a metronome individuals with PD 
had less variable movement such that they were no longer different than healthy controls 
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(del Olmo et al., 2006; del Olmo & Cudeiro, 2005). Thaut et al. used EMG to examine 
muscle activation and found that three weeks of gait exercises paced using rhythmic 
auditory stimulation (cueing beats infused into music) resulted in a change towards a 
more normal muscle activation pattern during gait (Thaut et al., 1996). Other sensory 
techniques that have been explored further complicate the search for an answer. Mental 
imagery resulted in an improvement in UPDRS (Tamir et al., 2007), Qigong resulted in 
no improvement in UPDRS (Burini et al., 2006), and tai chi did not measure UPDRS (Li 
et al., 2007). Although the measures used have been inconsistent, sensory cueing 
techniques have generally had greater positive benefits than traditional exercise and 
therefore warrant further investigation. 
The use of external cues in exercise rehabilitation has been promising; however, it 
may not be the optimal approach. While lines taped on the ground have been able to 
increase step length in individuals with PD, this approach is not transferable as lines are 
not taped on sidewalks or mall floors. Similarly, auditory cues may be transported 
through portable auditory devices but may require attentional demands that place a 
person at increased risk. If a person must focus on the beats of a metronome coming 
through headphones while walking through a busy shopping mall they may actually have 
increased difficulty with the multiple demands of listening to the beat while maneuvering 
around obstacles (people, benches, signs, etc.). Thus, other more permanent techniques 
with potential to improve functioning among individuals with PD need to be investigated 
in rehabilitation settings. 
One area that has recently received considerable research interest in terms of its 
role in PD is the influence of the basal ganglia on sensorimotor integration, especially 
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during motion. It has been seen that individuals with PD exhibit an abnormal central 
processing of proprioceptive input which provides an inaccurate internal representation of 
the body's motion (Jacobs & Horak, 2006). Sensorimotor integration has generally been 
investigated under conditions restricting or allowing vision. For example, Almeida et al. 
examined individuals with PD after withdrawing dopaminergic medication and again at 
peak dose of dopaminergic medication under four conditions which altered the feedback 
available. The task had participants in complete darkness, then a target LED was 
illuminated, turned off and participants were instructed to move to that target. One 
condition of interest, illuminated the target LED for three seconds, and then had 
participants walk towards the target in complete darkness; therefore, only proprioceptive 
feedback was available. Interestingly, on medication individuals with PD had 
significantly less error (2D radial error from target once participant stopped walking) then 
individuals off their medication. As the optimally functioning basal ganglia (on 
medication) resulted in less error than the poorly functioning basal ganglia (off 
medication) it was suggested that the basal ganglia is a critical component involved in 
integrating proprioceptive feedback during movement (Almeida et al., 2005). 
Applying the identified proprioceptive integration deficit to a rehabilitation 
setting has never been attempted in Parkinson's disease. Thus, an important aim of the 
current thesis was to determine if an exercise program focused on the sensorimotor 
deficit is beneficial for individuals with PD. Further, this exercise program [Sensory 
Attention Focused Exercise (PD SAFEX)], was compared to traditional forms of exercise 
including aquatic, aerobic and strength/resistance training and a non-exercise control 
group. The variety of exercise rehabilitation trials previously evaluated used different 
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outcome measures and did not allow for adequate comparisons to be made between the 
interventions. Therefore, reaching an ultimate conclusion on the efficacy of exercise as an 
alternative treatment to PD is not currently feasible. Another main focus of the current 
thesis was to compare various exercise interventions using identical outcome measures to 
attempt to answer the question of which exercise program is the most beneficial for 
individuals with PD. 
As should apply to any potentially beneficial therapeutic intervention, ensuring 
that the effectiveness can be replicable is important. As such, an important aspect of this 
thesis was to compare symptomatic changes resulting from a sensory attention focused 
exercise (PD SAFEX) program that was administered numerous times. Additionally, the 
effectiveness of the PD SAFEX program was evaluated to determine the ability of the 
program to be run in community based situations by individuals with minimal training in 
movement disorders. 
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Thesis Objectives 
The main objective of the current thesis was to identify the optimal exercise 
strategy for individuals with Parkinson's disease. To address this objective the following 
four chapters will investigate important questions and attempt to improve upon 
shortcomings of previous work. The first chapter evaluates the ability of objective 
outcome measures to reflect changes identified through clinical evaluation with the 
Unified Parkinson's Disease Rating Scale. The purpose was to determine which outcome 
measures provide the most information regarding specific improvements in PD symptoms 
to identify the most disease relevant measures for use in exercise rehabilitation trials. 
The second chapter compares various exercise strategies to determine which 
exercise strategy is the most effective for individuals with PD. A number of shortfalls in 
previous research were controlled for including, similar lengths of exercise intervention, 
identical symptomatic outcome measures, and comparison with a non-exercise control 
group to allow for adequate comparison between exercise interventions. 
Chapters three and four focus on a specially designed exercise program, Sensory 
Attention Focused Exercise (PD SAFEX) that required participants to rely on 
proprioceptive feedback to properly complete each exercise. Chapter three compared the 
PD SAFEX program to a similar exercise program that did not focus on proprioceptive 
feedback. Chapter four addressed the replicability of the PD SAFEX program to determine 
whether the program provided consistent results. Additionally, the ability of the PD 
SAFEX program to be administered by individuals in the community with minimal 
training was evaluated. 
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Finally, a concluding chapter provides a summary of the findings and provides 
suggestions for the optimal exercise strategy for individuals with PD. 
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CHAPTER 2 
THE RELATIONSHIP BETWEEN OBJECTIVE OUTCOME MEASURES AND 
SYMPTOMATIC ASSESSMENT OF PARKINSON'S DISEASE 
ABSTRACT 
Limited work has been conducted to identify specific and objective outcome 
measures that reflect symptomatic change in Parkinson's disease (PD). The current study 
aimed to determine which measures were best able to predict PD symptoms, measured 
using the Unified Parkinson's Disease Rating Scale (UPDRS) and also which measures 
were reflective of symptomatic changes. One hundred and eleven participants were 
assessed as part of a large exercise rehabilitation trial in PD at the Movement Disorders 
Research and Rehabilitation Centre, Wilfrid Laurier University. Outcome measures 
included the Unified Parkinson's Disease Rating Scale (UPDRS), Timed-Up-and-Go 
(TUG), place and remove phase of the Grooved Pegboard (GP) on both the affected and 
non-affected sides, and spatiotemporal aspects of self-paced gait. Participants were 
assessed before commencing exercise (pre-test) and immediately following the end of the 
twelve week program (post-test). The first analysis was a backward elimination linear 
regression using all outcome measures to predict overall UPDRS. The place phase of the 
GP on the non-affected side was found to be the most predictive of UPDRS score, 
accounting for 26.9% of the variability in UPDRS score. The second analysis was to 
determine the ability of secondary outcome measures to reflect symptomatic changes 
identified through the UPDRS. Correlation analysis was conducted to determine the 
relationship between the TUG and GP and specific subsets of the UPDRS that were 
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chosen to represent the areas assessed by the TUG and GP. Percent change [(pre-test -
post-test)/pre-test x 100%] was used to standardize the measures, and control for pre-test 
disease severity. No significant relationships between the UPDRS subsets and their 
corresponding outcome measures were identified. As no objective measures were seen to 
have a relationship with the UPDRS symptom severity scale, the results suggest that both 
measures should be inspected to ensure that improvements are reflective of symptomatic 
improvement. 
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INTRODUCTION 
Parkinson's disease (PD) is a debilitating movement disorder with symptoms that 
can often restrict movement, be accompanied with pain, and limit independence. 
Symptoms such as tremor, rigidity, and poor mobility are typically treated with dopamine 
replacement agents, although long-term administration of dopamine can lead to 
debilitating side-effects such as dyskinesia (involuntary movements of the head and 
arms), hallucinations and sleep disorders (Leung & Mok, 2005). Thus, the search for 
effective alternative therapies to complement and decrease reliance on medication is 
important for the PD community. 
Various exercise strategies have been investigated for their benefit for individuals 
with PD; however, no consensus on recommendations can currently be made (de Goede, 
Keus, Kwakkel, & Wagenaar, 2001; Deane et al., 2002). One of the problems plaguing 
previous research is the inconsistent use of symptom specific outcome measures. For 
example, a large study into the effects of sensory cued exercises (n=153) by Nieuwboer 
et al. had participants complete mobility exercises with a physiotherapist. The outcome 
measures were a posture and gait score, spatiotemporal aspects of self-paced gait (step 
length, velocity, cadence), single and double leg stance tests, the timed-up-and-go, and a 
number of questionnaires (Nieuwboer et al., 2007). While the exercise intervention did 
reveal positive effects on the posture and gait score, spatiotemporal aspects of gait, and 
stance tests, it is unclear whether these benefits are symptom specific or general 
musculoskeletal improvements. It has also been suggested that physical therapy can 
influence mobility more easily than neurological symptoms (de Goede et al., 2001). 
Further, specific impairments (step length, velocity) can be easily altered and measured 
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but may have little benefit for the patient in their day to day life (Deane et al., 2002). 
Thus, while Nieuwboer et al. (2007) were able to influence mobility, it is unclear what 
effect the exercise had on global PD symptoms. 
Exercise interventions in PD should be aimed at improving neurological function 
and ultimately improved PD symptoms. Thus, the outcome measures used should be 
symptom specific and reflect clinical symptomatic measures. In a strength training 
intervention, it was found that individuals with PD improved muscle strength following 
the training (Hirsch, Toole, Maitland, & Rider, 2003). However, the question remains are 
these benefits symptom specific or was the increased muscle strength a benefit that any 
individual would receive from strength training. With no PD symptomatic measure, the 
relative impact of the exercise on PD cannot be determined. 
Clinically, PD symptoms are measured using the Unified Parkinson's Disease 
Rating Scale (UPDRS) (Fahn, 1987). The UPDRS is the current gold standard and has a 
trained clinician rate each PD symptom using a scale from zero to four (zero represents 
no symptoms present and four represents the most severe symptoms). It is also the most 
critical measure used to identify symptom improvement when approving new drug 
treatments for PD. The UPDRS measures disease severity and provides an approximation 
of the neurological functioning of the basal ganglia as more severe PD symptoms result 
from more severely impaired basal ganglia. Thus, the UPDRS is currently the best 
available clinical measure for determining the symptom specific effect of exercise. 
However, using the UPDRS is not feasible for all researchers or individuals in the 
community who may be administering exercise programs to individuals with PD. For 
instance, a trained UPDRS evaluator is not always accessible to researchers and tracking 
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the progress of an individual with PD in a non-research based environment can be 
difficult for individuals without specialized training such as an exercise leader. 
Additionally, the UPDRS for all its benefits is still a subjective rating by a clinician. 
Thus, the main objective of the current study was to determine the most useful objective 
outcome measures for use in research and community environments that are 
representative of symptom changes identifiable with the UPDRS. Furthermore, while it 
might be ideal to evaluate participants on a wide range of outcome measures including 
brain scans, the current study attempted to gain a holistic assessment of participants under 
realistic testing conditions (approximately one hour). 
Identifying measures that are most representative of PD symptoms is an important 
undertaking, as limited work has been conducted in this area. The only research that has 
focused on this type of question attempted to establish whether level of disease severity 
might predict the potential benefit received from physiotherapy (Nieuwboer, De Weerdt, 
Dom, & Bogaerts, 2002). However, the dependent variable was a Parkinson's activity 
scale developed to focus on functional abilities that, might be altered through 
physiotherapy, and UPDRS score at baseline was one of the predictor variables 
(Nieuwboer et al., 2002). The results indicated that those with a lesser degree of severity 
were more likely to benefit from physiotherapy interventions (when compared to more 
severe individuals with PD). Another interesting study attempted to correlate specific PD 
symptoms with nigrostriatal dopaminergic deficit, however, a modified Columbia scale 
was used to assess symptoms which, although similar to the UPDRS is less commonly 
used in PD research (Vingerhoets, Schulzer, Calne, & Snow, 1997). Thus, the current 
study was unique as it attempted to not only determine which outcome measures are most 
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predictive of disease severity as reflected by UPDRS score but more importantly, tested 
participants before and after exercise to determine which objective outcome measures 
might be useful indicators of symptomatic changes. 
METHODS 
Participants 
As part of a large research project into the effect of exercise on PD at the 
Movement Disorders Research and Rehabilitation Centre (MDRC) at Wilfrid Laurier 
University, one hundred and eleven participants (F=42, M=69, age=67.1, SD=9.1) with 
idiopathic PD were utilized in the current study. Testing took place from September 2006 
to December 2007, and represented four rounds of exercise (fall 2006, winter 2007, 
summer 2007, and fall 2007) at four sites across southern Ontario (including the MDRC, 
and three YMCA's in Kitchener, Cambridge, and Oakville, Ontario). A single participant 
could have participated in all four rounds of exercise, thus, to control for the potential 
effect of multiple administrations of exercise and ensure independency of observations, 
the 111 participants included in the current study were involved in their first round of 
exercise (or were part of a non-exercise control group). 
Multiple exercise strategies including aerobic training, strength training, aquatic 
exercise, and sensory feedback based exercise were administered. Additionally, 
participants unable to commit to the requirements of an exercise program were enlisted as 
part of a non-exercise waitlist control group. Each exercise program lasted between 10-12 
weeks, or 30-36 classes depending on when the program was completed (due to seasonal 
holidays), followed by a six week period with no exercise. Participants were required to 
exercise three times per week regardless of the exercise program. Additionally, all 
participants, including non-exercise control participants, were instructed to maintain their 
current medication schedule and regular physical activity for twelve weeks. Thus, the 
only addition to a participant's regular schedule was the exercise intervention being 
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investigated. Since the focus of the current study was to find outcome measures that 
would reflect PD symptoms, the exercise groups were collapsed (for more detail on the 
specific exercise strategies investigated please see Chapter 3). This research was 
approved by the research ethics board at Wilfrid Laurier University and all subjects 
signed informed consent forms before commencement of the study. 
Clinical Symptom Assessment 
The Unified Parkinson's Disease Rating Scale motor section (UPDRS) (Fahn, 
1987) was the primary outcome measure, as it provided an overall assessment of the 
motor symptoms of PD. A single certified evaluator (blinded to group assignment) 
performed all UPDRS evaluations while participants' were at their peak dosage of anti-
parkinsonian medication. The UPDRS motor section is composed of fourteen items. 
Some of these items are repeated on each upper or lower limb to reflect symptoms that 
may be present in each appendage. Each item (or symptom) was rated on a scale ranging 
from zero to four, where zero represented no identifiable symptoms present and four 
represented the most severe symptoms; as such, the highest severity score possible was 
108. The UPDRS was used as the dependent variable in the regression analysis, while the 
objective outcome measures (timed-up-and-go, self-paced gait, grooved pegboard) were 
used as predictors. Additionally, subsets of the UPDRS were calculated to determine if 
changes in objective outcome measures were reflective of the specific symptomatic 
changes they entailed. The specific UPDRS items used to calculate each subset are 
explained in more detail below. 
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Functional Gait 
The Timed-Up-And-Go (TUG) was used to measure gait during a functional task, 
as it required a sequence of movements including sit to stand, initiation of gait, and 
dynamic balance control while turning. Each trial began with the participant in a seated 
position in a standard office chair with armrests (All Seating Corporation, Model 
No.3307). Participants were instructed to stand up, walk to a target three meters away, 
turn around and return to a seated position in the chair as quickly as possible. Timing 
began upon movement initiation (participant's back breaking contact with the chair) and 
ended when the participant made contact with the chair in a seated position. The TUG 
was completed twice and an average of the overall time for completion of the two trials 
was used in statistical analysis. 
A posture and gait (PG) score was calculated as a subset of the UPDRS to 
examine its relationship with the TUG. The subset included items 27 (arising from a 
chair), 28 (Posture), 29 (Gait), 30 (Postural Stability), and 31 (Body Bradykinesia). These 
specific items were chosen as they have been suggested to be the clinical indicators of 
posture and gait impairment according to the UPDRS (Sage & Almeida, In Press). 
Upper Limb Motor Control and Bradykinesia 
Upper limb motor control was assessed using the Grooved Pegboard (GP) 
(Lafayette Instruments # 32035). The typical administration of the GP involves placing 
25 pegs into key shaped slots as quickly as possible. However, a new administration of 
the GP, which is more applicable to the aims of the current study, was used and involved 
both the standard place phase and a remove phase where the 25 pegs were subsequently 
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removed from the slots and placed in a large receptacle (Bryden & Roy, 2005). The two 
phases measured different movement characteristics as the place phase tested fine 
visuomotor control while the remove phase was more a test of movement speed (Bryden, 
Roy, Rohr, & Egilo, 2007). 
The current study required participants to complete both the place and remove 
phase twice with each limb. The initial limb tested was randomly selected with the 
subsequent testing order being the place phase followed by the remove phase, alternating 
the limb. If a participant was unable to complete the task in five minutes, a count of pegs 
completed was taken; the remove phase or a second trial of the place phase was not 
completed. Participants completing the task in four to five minutes did not complete a 
second trial with that limb and their first trial was taken as the average. These criteria 
were enforced to ensure testing placed reasonable demands on participants. To include as 
many participants in analysis as possible an average rate of time per peg was calculated 
for each limb and phase and was used for data analysis. 
Times from the GP were analysed separately based on the most and least affected 
limbs. To determine the most and least affected side, a score was calculated using all side 
related items of the UPDRS. Both upper and lower limb items were included (even 
though the GP is an upper limb task) to determine the most degenerated side of the basal 
ganglia, which corresponds to the contralateral side of the body with the most severe 
symptoms. Thus, four rates resulted from each participant: affected and non-affected 
place phase, and affected and non-affected remove phase. 
The GP rates were compared with specific subsets of the UPDRS, selected to 
represent the components of each phase of the GP. An upper limb affected and non-
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affected score was calculated for each side, using all upper limb side related items from 
the UPDRS: 20 (resting tremor), 21 (action tremor), 22 (rigidity), 23 (finger taps), 24 
(hand movements - open and close hands quickly), and 25 (rapid alternating movements 
of hands - pronate and supinate). The upper limb subset was analysed with the place 
phase of the corresponding limb to determine if a relationship existed. Secondly, an upper 
limb bradykinesia score was calculated following previous work that used UPDRS items 
23-26 to calculate a limb bradykinesia score (Marchese, Diverio, Zucchi, Lentino, & 
Abbruzzese, 2000). The current study, however, utilized items 23-25 which represent 
quick hand movements important to complete the GP quickly and not item 26 (leg 
agility) which has no direct influence on the GP task. The limb bradykinesia score was 
analyzed with the corresponding remove phase of the GP. 
Spatiotemporal Aspects of Self-Paced Gait 
Gait was measured as participants walked at their comfortable pace over a four 
meter pressure-sensitive carpet (Gaitrite®, CIR Systems Inc., Clifton, NJ). Participants 
began each trial a minimum of two steps before the carpet and continued walking a 
minimum of two steps beyond the end of the carpet to ensure that acceleration and 
deceleration did not contribute to the data collected. Five measurement trials were 
averaged and used for statistical comparisons. The spatiotemporal aspects of gait 
analyzed were step length and velocity as these are the gait characteristics most directly 
evaluated as part of the UPDRS assessment. 
Due to the potential confounding effect of height on a participant's step length the 
step length values were divided by an individual's height. Height has no theoretical 
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bearing on UPDRS scores, while decreased step length does as it is assessed as part of the 
UPDRS. However, a person who is 180cm and takes a 45cm step is clearly more 
impaired than a person who is 140cm and also takes 45cm steps. Thus, dividing step 
length by height provided a more accurate reflection of impairment than step length 
alone. 
Velocity and step length were included as part of the regression analysis but were 
not incorporated as part of the correlation analysis because only one item on the UPDRS 
(29 - Gait) directly assesses self-paced velocity and step length; hence, no acceptable 
UPDRS subset could be calculated. 
Statistical Evaluation 
Since the focus of the current study was not to identify differences between the 
exercise interventions, pre-test scores from all exercise groups were collapsed. The first 
analysis was a backward elimination linear regression to determine which outcome 
measures were best able to predict overall UPDRS motor score, with F probability for 
removal set at p >.10. Backward elimination regression was chosen due to the 
exploratory nature of the model and the lack of theoretical predictions for outcome 
measures that would be more influential on UPDRS score. This procedure allowed all 
variables to enter the model and the least important predictors were removed until only 
the most predictive variables remained. Measures from testing completed before 
participants began the exercise program (pre-test) were used in the regression analysis. 
Only participants that completed every testing component were included in the regression 
and this represented 86 participants: two did not complete the Timed-Up-and-Go and 
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twenty-three were missing grooved pegboard data (primarily participants that did not 
complete the remove phase). 
The second analysis was to examine the relationship between changes observed 
on the outcome measures and the specific subset of the UPDRS for which they were 
theoretically representing. The tests before commencement of the exercise program (pre-
test) and immediately following the exercise program (post-test) were used to determine 
changes resulting from exercise. In an attempt to standardize the measures based on 
disease severity (a five point change on the UPDRS carries different weight if pre-test 
UPDRS score is twenty versus fifty), the difference from pre-test to post-test was 
converted to a percent change for each outcome measure. The percent change calculation 
was designed so a positive percent change signified improvement. For all outcome 
measures included in the correlation analysis (UPDRS, TUG, GP) a lower score indicated 
improved performance, the percent change calculation was: (pre-test - post-test)/pre-test 
x 100%. 
The specific relationships analyzed were: i) TUG and posture & gait (PG) score; 
ii) GP place phase and upper limb UPDRS score (both affected and non-affected side); 
and, iii) GP remove phase and upper limb bradykinesia score (both affected and non-
affected side). Participants unable to complete testing on one of the outcome measures or 
whose results were deemed to be outliers with potentially excessive influence on the 
relationship were removed from analysis pairwise. Outliers were generally the result of 
participants with low scores in the UPDRS subsets, where a small change (1 or 2 points) 
resulted in a large percent change. For example, one participant went from a 0.5 on the 
PG score at pre-test to a 3.5 at post-test, representing a -600% change. To minimize the 
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influence of large percent change on one variable, all percent changes with magnitude 
greater than 100% were removed pairwise from the correlation analysis. Additionally, 
participants with a score of 0 on a UPDRS subset at pre-test were removed from analysis 
since an improvement beyond zero symptoms identified would be impossible (i.e. 
denominator would equal 0). Thus, following these guidelines eight participants were 
removed from the PG score; two from the TUG; six from the upper limb affected side 
UPDRS score; fifteen from the place phase of the GP for the affected side; twelve from 
the upper limb non-affected side UPDRS score; twelve from the place phase of the GP on 
the non-affected side; nine from the affected side upper limb bradykinesia score; twenty-
three from the remove phase of the GP on the affected side; nineteen from the non-
affected side upper limb bradykinesia score; and, fifteen from the remove phase of the 
GP on the non-affected side. 
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RESULTS 
Predicting UPDRS 
All predictor variables were significantly correlated with overall UPDRS score, 
and were normally distributed with no outliers (standardized residual of more than 3 std. 
dev.) significantly influencing the regression model. Table 1 displays the mean and 
standard deviation for each measure at pre-test. The first model included all seven 
predictor variables and accounted for 0.326 (adjusted R2 = 0.266) of the variability in 
UPDRS score with a linear regression equation of: 
UPDRS = 17.189 - 0.045 (TUG) + 1.305 (GP Place Affected Side) + 1.292 (GP Place 
Non-Affected Side) - 6.902 (GP Remove Affected Side) + 6.680 (GP 
Remove Non-Affected Side) -0.045 (Gait Velocity) + 0.811 (Step 
Length/Height) 
However, this model violated a number of the assumptions of multiple regression, 
namely multicollinearity typified by the step length/height variable which had a low 
tolerance of 0.156, high variance inflation factor of 6.409, and a high condition index of 
58.784. Additionally, in the first model the only predictor variable with a significant 
contribution was the GP place phase on the affected side (t = 2.16, p = .034). Thus, 
subsequent models were created as the predictor variables with the lowest partial 
correlations with UPDRS score were removed. The order of removal was step 
length/height (R2 change <.001), TUG (R2 <.001), gait velocity (R2 = -.01), GP remove 
affected side (R2 = -.013), and GP remove non- affected side (R2 = -.005). Thus, the final 
model included the GP place on the affected side and the GP place on the non-affected 
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side and explained 0.297 (adjusted R2 = .280) of the variance in UPDRS with a standard 
error of 7.06. The linear regression equation for the final model was: 
UPDRS = 10.396 + 0.905 (GP Place Affected Side) + 1.971 (GP Place Non-Affected 
Side) 
While the model did pass most of the necessary assumptions of multiple 
regression including independence of errors (Durbin-Watson = 1.698), normally 
distributed residual error, and homoscedasticity; the high correlation between the two 
remaining variables (r = .666) required careful consideration of multicollinearity. The 
tests for multicollinearity were mostly passed (tolerance >.5, variance inflation factor < 
2.5, condition indices < 15). Although, the condition indices were considered low ( < 9), 
the high variance proportions (affected side = .65, non-affected side = .95) for the two 
coefficients on the condition index for factor 3 raised concern of linear dependence and 
multicollinearity problems. While the correlation between the place phases for affected 
and non-affected limbs was understandable with the identical task being repeated for each 
limb, both place phases were originally included in the regression analysis since they 
might represent PD symptoms on the corresponding side. Since both place phases were 
the only predictor variables left in the model following backward elimination regression 
analysis, an additional model was analyzed using just the GP non-affected side to predict 
UPDRS. 
The non-affected side was chosen as it had a higher standardized Beta (Beta = 
.367) than the affected side (Beta = .227); a higher variance proportion (.95 versus .65) 
on the condition index for factor 3; and the test of prediction significance for the GP 
place phase on the affected side was non-significant at a .05 level, (t=1.753, p >.05). This 
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indicated that the GP place on the non-affected side was contributing more to the model 
then the GP place on the affected side. The new model was significant (F = 30.837, 
p<.001) and the GP place on the non-affected side was able to account for .269 
(standardized R2 = .260) of the variability in UPDRS with a standard error of 7.16. The 
prediction equation was: 
UPDRS = 11.636 + 2.782 (GP place non-affected side). 
Overall, the prediction model including the GP place phase for both the affected 
and non-affected side of the body was significant and able to account for .297 of the 
variability in UPDRS. The model containing only the GP place phase on the non-affected 
side was also significant and still able to account for .269 of the variability in UPDRS (a 
difference of only .028). Thus, the GP place phase on the affected side only accounted for 
an additional 2.8% of the variability in UPDRS. The significance of the model containing 
only the GP place phase for the non-affected side and the minimal increase in the percent 
of UPDRS variability when the affected side is included suggests that multicollinearity 
between the GP place phases on the affected and non-affected sides was a substantial 
problem with the regression analysis. 
Correlation analysis of symptomatic changes 
None of the correlations investigated reached statistical significance. Table 2 
displays the sample size, correlation coefficient and p-value for each of the relationships 
investigated. The TUG and PG score relationship (r = -.036, p>.05); GP place phase and 
corresponding upper limb score relationship (affected side, r = -.090, p>.05, non-affected 
side, r = -.057, p>.05); and, GP remove phase and corresponding limb bradykinesia score 
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relationship (affected side, r = .069, p>.05, non-affected side, r = -.009, p>.05) all had 
low correlation coefficients suggesting that no relationships existed between the 
variables. 
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DISCUSSION 
Predicting UPDRS 
The grooved pegboard (GP) was found to be the most useful tool to predict 
UPDRS score. Specifically, the backward elimination regression analysis indicated that 
the grooved pegboard (GP) place phase for both the affected and non-affected body side 
were the best predictors of UPDRS score (accounted for .297 of the variability in 
UPDRS). However, due to the multicollinearity between the variables a new model was 
created using GP place phase on the non-affected side which was also significant and 
able to account for .269 of the variability in UPDRS. Thus, the regression analysis 
suggests that the place phase of the GP on the non-affected body side is the best predictor 
of UPDRS scores. 
The order of removal of the predictor variables from the regression model seems 
to be logical for several reasons. The three gait related variables were the first to be 
removed from the model. While gait is assessed as part of the UPDRS it is only directly 
measured by one item. Due to the under-representation of gait measurement on the 
UPDRS, changes in step length, velocity or the TUG are not likely to appreciably 
influence change on the UPDRS. Also, gait variables were highly correlated with each 
other and as witnessed in the first model violated assumptions of multicollinearity. It was 
surprising, however, that the TUG was the second variable removed from the model. The 
TUG measures sequential locomotor movements including walking and turning (Morris, 
Morris, & Iansek, 2001) and has been suggested to be a clinical indicator of posture and 
gait deficits that may be directly represented on the UPDRS such as sit-to-stand, gait, 
postural stability and bradykinesia (Sage & Almeida, In Press). Since a significant 
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correlation did exist between the TUG and UPDRS (and was higher than the correlation 
between velocity and UPDRS, and also step length/height and UPDRS), further study is 
warranted to investigate the utility of the TUG in identifying symptomatic changes in PD. 
Conversely, the inclusion of the place phase of the grooved pegboard (both 
affected and non-affected side, and non-affected side alone) in the final two models was 
logical as a number of items measured on the UPDRS would directly affect performance 
on the GP. UPDRS items 20 (resting tremor, measured separately for each limb), 21 
(action tremor, measured separately for each upper limb), 22 (rigidity, measured 
separately for each limb), 23 (finger taps, measured separately for each limb), 24 (hand 
movements, measured separately for each limb), 25 (rapid alternating movements of the 
hands, measured separately for each limb), and 31 (body bradykinesia) would have a 
direct effect on performance on the GP. Thus, performance on the place phase of the GP 
would be expected to have predictive utility for assessing symptoms measured with the 
UPDRS. 
The finding that an upper limb pegboard task was the most predictive UPDRS 
scores is in line with previous work (Bohnen, Kuwabara, Constantine, Mathis, & Moore, 
2007; Vingerhoets et al., 1997). Vingerhoets et al. found a significant correlation between 
scores on a purdue pegboard and nigrostriatal dopaminergic deficit (Vingerhoets et al., 
1997), similar to our finding of a significant relationship between the grooved pegboard 
UPDRS scores. More relevant to the current study, Bohnen et al. compared scores on the 
place phase of the GP to nigrostriatal denervation and observed a significant correlation 
between the least affected arm and denervation of the corresponding basal ganglia 
(Bohnen et al., 2007). The finding was thought to be the result of a wide range of GP 
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times and dopaminergic denervation on the least affected side, while no relationship was 
found on the most affected side due to a statistical 'floor' associated with the more 
severely denervated basal ganglia and a statistical 'ceiling' with GP times (Bohnen et al., 
2007). Since a rate (time/peg) was used to assess the GP, participants representing a wide 
range of disease severities were included in analysis and the current study would not be 
subject to the same degree of 'ceiling' effect on GP times. Hence, the current finding that 
the relationship between the non-affected place phase of the GP and overall UPDRS 
score (r = .518) had the highest correlation and was the best predictor of UPDRS scores 
accurately confirms the findings of previous work. 
Although there are limitations to the current models they are an intriguing starting 
point. The two models were only able to account for less than 30% of the variability in 
UPDRS, leaving a large portion (>70%) unaccounted for. To improve the predictive 
power of the model, future studies might increase the sample size and investigate 
additional variables that may account for UPDRS score. Additionally, adjustments to 
improve the multicollinearity issues between the affected and non-affected side GP place 
phases may benefit the model. It is unlikely that centering the data would appreciably 
affect the multicollinearity of the two place phases as the tasks are identical. Similarly, 
dropping the affected side place phase from analysis is not ideal as the GP place phase 
from each limb is thought to be testing different aspects measured by the UPDRS. 
Perhaps a future strategy would be to combine the variables (i.e. crossproduct) so that 
both remain in the model as one new variable rather than two. 
Given the originality of the current study, the final regression models (with either 
both GP place phases or just the non-affected side) do provide a satisfactory starting point 
/ 
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for prediction of symptom severity (as represented by UPDRS score). Unfortunately, the 
models had a high standard error of prediction and only accounted for a low amount of 
variability in UPDRS. The findings do suggest that other measures may be better 
representations of PD symptoms. Of concern is the removal of all mobility measures in 
the first steps of regression analysis which suggests that previous research that used 
mobility outcome measures without also measuring PD symptoms provides an 
incomplete picture. Functional mobility measures are easy to conduct and provide 
important information; however, as they are not reflective of the UPDRS they do not 
seem to provide disease specific information and must be interpreted cautiously. 
Conversely, the UPDRS may be too focused on the upper limb and the lower limb and 
mobility measures may be underrepresented. Ideally, future research would include 
analysis of outcome measures that predict neurological functioning of the basal ganglia to 
address the potential limitations of the UPDRS. 
Correlation analysis of symptomatic changes 
The correlational analysis was of particular importance to the current study as the 
goal was to determine which outcome measures are best able to replicate clinical 
symptomatic changes. Each outcome measure tested was carefully chosen as it was 
thought to reflect specific PD symptoms, thus it was perplexing that none of the 
relationships investigated reached statistical significance. Further, common methods to 
increase power and improve the chances of finding significance such as increasing 
sample size would not likely affect the relationships in the current study as the 
correlations were very small (r < . 1, for all relationships) and the sample size was 
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relatively large. Thus, the current findings suggest that none of the measures tested were 
acceptable supplements of clinical assessment using the UPDRS. 
One potential reason for the lack of relationship between the change on the 
UPDRS subset and the corresponding outcome measure is the potential practice effect. 
Bias should not be affecting the UPDRS assessment as the clinician was blinded and 
participants cannot improve their ability on the UPDRS assessment (i.e. they cannot hide 
their symptoms). However, the outcome measures may be subject to practice effects, 
where a participant gains information about the TUG or GP and improves their 
performance at post-test simply from a better understanding or greater experience with 
completion of the required task. Thus, a participant may have an increased UPDRS 
subset score (worsened symptoms) but still display an improvement on the GP or TUG. 
This situation would decrease the magnitude of the relationship and may have been 
present in the current correlation analysis as the Pearson's correlation coefficients were 
all near zero. A scan of the posture and gait (PG) score and TUG percent improvements 
displayed 15 participants that had an increased PG score (negative percent change) and 
an improved TUG (positive percent change). Outcome measures that may be less 
influenced by practice would be valuable to investigate, and may reveal the expected 
relationship with UPDRS subsets. 
Although the lack of relationship between the outcome measures and the 
corresponding UPDRS subset is surprising, it speaks to the importance of combining 
outcome measures with a PD symptomatic assessment to determine the disease specific 
effect of the exercise technique. For example, Miyai et al. evaluated a mobility based, 
body-weight supported treadmill training (BWSTT) program in two separate groups. 
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While both groups realized mobility gains following exercise, the first group had 
improved UPDRS scores and the second had no significant change on the UPDRS (Miyai 
et al., 2000; Miyai et al , 2002). The mobility measures suggested that BWSTT was 
beneficial in PD, but the UPDRS assessment suggested that BWSTT may not be 
effective. Analysis of objective measures is important but should be considered in 
relation to the specific aims of the exercise program. A mobility based program would be 
expected to improve mobility in any population but without improvement in a symptom 
specific manner, it may not be the optimal exercise strategy for use in PD. Thus, the lack 
of relationship between the outcome measures and UPDRS subsets found in the current 
study suggests that PD exercise rehabilitation trials without a PD symptomatic measure 
provide an incomplete picture of the effects of the exercise intervention and should be 
interpreted with caution. Nevertheless, functional outcome measures should not be 
abandoned as they may reveal important changes representative of functional ability 
within one's home environment. 
Conclusions 
The regression analysis suggested that the place phase of the grooved pegboard 
(GP) was the best predictor of PD symptoms. The GP, or any measure of upper limb 
motor control, however, has not been used extensively in PD exercise rehabilitation trials. 
Future research should evaluate other objective measures that are representative of PD 
symptoms and exercise trials should consider including an assessment of upper limb 
motor control such as the GP. Unfortunately, the correlation analysis did not reveal any 
objective outcome measures that reflected PD symptomatic changes identified through 
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the UPDRS. As such, future work should continue to build on the current study to 
determine the optimal outcome measures for use in PD exercise rehabilitation research. 
As the relationship between objective measures and the UPDRS is unclear, both 
should be included and results scrutinized to ensure that improvements are relevant in a 
symptom specific manner before an exercise trial is deemed successful. 
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Table 1 - Mean and standard deviation for each outcome measure at pre-test. 
UPDRS 
subsets 
Objective 
Measures 
MEASURE 
UPDRS 
PG score 
Affected side upper limb score 
Non-affected side upper limb score 
Affected side upper limb bradykinesia score 
Non-affected side upper limb bradykinesia 
score 
TUG (s) 
Affected side GP place phase (s/peg) 
Non-affected side GP place phase (s/peg) 
Affected side GP remove phase (s/peg) 
Non-affected side GP remove phase (s/peg) 
Velocity (cm/s) 
Step Length (cm)/height (cm) 
UPDRS, Unified Parkinson's Disease Rating Scale; PG, postur 
MEAN 
26.1 
4.6 
8.1 
4.5 
5.2 
2.9 
9.4 
6.3 
5.0 
1.2 
1.1 
113.1 
0.35 
Std Dev 
10.1 
3.6 
2.6 
2.7 
2.1 
2.0 
3.6 
3.5 
2.2 
0.3 
0.3 
24.0 
0.05 
e and gait; TUG, timed-
up-and-go; GP, grooved pegboard. 
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Table 2 - Sample size and correlation between percent change on objective outcome 
measures and corresponding UPDRS subset. 
RELATIONSHIP 
TUG & PG score 
Affected side GP place phase & upper 
limb UPDRS score 
Non-affected side GP place phase & 
upper limb UPDRS score 
Affected side GP place phase & upper 
limb bradykinesia score 
Non-affected side GP remove phase & 
upper limb bradykinesia score 
SAMPLE 
SIZE 
101 
96 
93 
85 
84 
CORRELATION 
-.036 
-.090 
-.057 
.069 
-.009 
* significant at p<.05 
TUG, Timed-Up-and-Go; PG, posture and gait; GP, grooved pegboard; UPDRS, Unified 
Parkinson's Disease Rating Scale 
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CHAPTER 3 
A COMPARISON OF EXERCISE STRATEGIES TO IMPROVE THE MOTOR 
SYMPTOMS OF PARKINSON'S DISEASE 
ABSTRACT 
The aim of the current study was to compare the effectiveness of four exercise 
interventions (aquatic, aerobic, strength, and sensory attention focused exercise) and a 
non-exercising control group to identify the optimal exercise strategy for individuals with 
Parkinson's disease (PD). To improve upon shortfalls of previous research each exercise 
intervention lasted an equivalent length of time and all participants were assessed by the 
same evaluator, blinded to group assignment, using the Unified Parkinson's Disease 
Rating Scale motor section (UPDRS). Testing was performed before exercises began 
(pre-test), immediately following exercise (post-test) and following a minimum six week 
non-exercise washout period (washout). Two statistical analyses were performed; the first 
utilized all 89 participants and compared the pre-test to post-test assessments in the 
exercise groups and the non-exercise control group. The second compared the four 
exercise groups and included washout testing. Percent change scores were also calculated 
to allow for adequate comparisons to be made between the groups regardless of pre-test 
disease severity. Results indicated that the sensory attention focused exercise (PD 
S AFEX) and strength training groups received the greatest benefit of exercise (pre-test to 
post-test and percent change) compared to the non-exercise control group. The lasting 
effects of the exercise interventions including the washout assessment was largely non-
significant but suggested that the PD SAFEX, strength training had some long-term 
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benefit. The methodological quality of the current study adds significant benefit to PD 
exercise rehabilitation literature and suggested that PD SAFEX and strength training 
warrant further exploration into their ability as an adjunct therapy in the treatment and 
management of PD. 
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INTRODUCTION 
Parkinson's disease (PD) is a chronic neurodegenerative movement disorder 
caused by a progressive deterioration of dopamine producing neurons in the substantia 
nigra, pars compacta of the basal ganglia (Wolters & Francot, 1998). Current treatment 
typically involves administering levodopa, a dopamine precursor that is metabolized to 
dopamine in the periphery, to replace the lost dopamine in the basal ganglia (Leung & 
Mok, 2005). Unfortunately, pharmacotherapy does not appear to delay the progression of 
PD (Guttman, Kish, & Furukawa, 2003). As such, medications are stop gap measures that 
are only able to mask the symptoms of PD, and alternative therapies are required to 
complement pharmacotherapy to improve the outcome for individuals suffering from PD. 
Alternative therapies may go beyond easing the physical impairments resulting 
from PD and help ease the increasing financial costs associated with treatment of PD. In 
Ontario, individuals with PD have been found to result in physician costs 1.4 times 
higher, spend more time in hospital, and incur medication costs 3.0 times higher than 
control subjects (Guttman, Slaughter, Theriault, DeBoer, & Naylor, 2003). Further, more 
than 90% of individuals with PD were found to be over the age of 60 (Guttman, 
Slaughter et al., 2003). With an aging society the prevalence of PD is likely to rise, thus, 
relatively inexpensive, adjunct therapies are of increasing importance. 
Evidence for the effectiveness of exercise as an adjunct therapy for PD has been 
derived from animal models. Rats and mice that had been induced with mild to moderate 
PD and exercised on a treadmill twice a day for only five (mice) or fifteen (rats) minutes 
showed significant sparing of striatal dopamine, its metabolites, and dopamine 
transporters compared to sedentary PD animals (Tillerson, Caudle, Reveron, & Miller, 
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2003). Unfortunately, in humans a consensus on the effectiveness of exercise therapy for 
PD has not been reached (de Goede, Keus, Kwakkel, & Wagenaar, 2001; Deane et al., 
2002). 
Countless exercise interventions have been attempted in PD, however, results 
have been inconsistent. Among the shortcomings, small sample size, variable lengths of 
intervention, differences in outcomes measured, omission of control groups, lack of a 
washout period are all factors that contribute to weak experimental designs. Exercise 
strategies focused on increasing mobility have been the most commonly attempted 
interventions (Johnson & Almeida, 2007), however, comparing exercise rehabilitation 
research focused on mobility is still difficult. Nieuwboer et al. used auditory and visual 
cues while exercising in participant's home environment and found increased gait and 
step length measured over ten meters (Nieuwboer et al., 2007). Sunvisson et al. took 
participants on daily walks through mountains to improve mobility and saw improvement 
on a posturo-locomotor-manual test that had participants lift an object, carry it 150 cm 
and place it on a shelf (Sunvisson, Lokk, Ericson, Winblad, & Ekman, 1997). Thaut et al. 
utilized rhythmic auditory stimulation, infusing beats into music, to pace various gait 
exercises and found increased step length and velocity measured over flat ground and up 
a step and down a ramp (Thaut et al., 1996). While those research projects were focused 
on mobility and generally found mobility improvements adequate comparisons between 
them cannot be made, since measures are so different. 
It should also be noted that mobility may be more easily influenced than 
neurological symptoms (de Goede et al., 2001), hence, an even more important concern 
with PD exercise research is the absence of a disease specific measure. Since the most 
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common symptoms of PD are physical movement impairments (i.e. tremor, rigidity, 
bradykinesia) it seems logical to include symptomatic measures such as the Unified 
Parkinson's Disease Rating Scale (UPDRS). If a healthy individual participates in a 
strength training intervention he would be expected to receive strength gains. Thus, if an 
individual with PD participates in strength training and witnesses strength gains but no 
disease specific symptomatic gains then it is reasonable to conclude that strength training 
was beneficial in a musculoskeletal sense but was not successful at improving the 
underlying neurological problems associated with PD and strength training may not be 
optimal for individuals with PD. Numerous exercise rehabilitation studies have claimed 
success without a symptomatic measure of PD (Caglar, Gurses, Mutluay, & Kiziltan, 
2005; Cakit, Saracoglu, Gene, Erdem, & Inan, 2007; Li et al., 2007; Lokk, 2000; 
Sunvisson et al., 1997; Thaut et al., 1996; Viliani et al, 1999) however, the actual disease 
specific success of these interventions remains unanswered. 
In the current study, four different exercise interventions and a non-exercise 
control group were compared using identical lengths of intervention (including a non-
exercise washout period), and participants were evaluated with the identical outcome 
measures (including PD specific symptom measures). The exercise interventions 
represented a range of typical exercise strategies used for PD, including aquatic based 
exercise, aerobic exercise (using a machine specially designed for movement impaired 
populations), and whole body strength training. Additionally, a sensory attention focused 
exercise (PD SAFEX) program was employed to help patients focus on potential sensory 
feedback deficits that have been recently identified in PD (Almeida et al., 2005; Jacobs & 
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Horak, 2006). Thus, the overall purpose was to determine the optimal exercise strategy 
for individuals with Parkinson's disease using a disease specific approach. 
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METHODS 
Participants 
Eighty-nine individuals with Parkinson's disease were assigned to either aquatic, 
aerobic, strength, sensory attention focused exercise, or were part of a non-exercise wait-
list control group. Participants were assigned to groups based on the exercise centre that 
was easiest to access and exercise interventions were administered based on the capacity 
of each facility. Inclusion criteria included a diagnosis of idiopathic Parkinson's disease, 
non-dementia, and a stable medication schedule. Participants were instructed to maintain 
their current medication dosage and regular physical activity schedule for the duration of 
the exercise intervention. Thus, the only addition to a participant's normal routine was 
the exercise program they were administered. For the first component of the current study 
twelve individuals participated in the aquatic exercise (0-F, 12-M; mean age=63.1, 
SD=9.2); seventeen participated in aerobic training (8-F, 9-M; mean age=65.8, SD=9.9); 
eighteen participated in strength training (9-F, 9-M; mean age=68.7, SD=8.3); twenty-
four completed sensory attention focused exercise (PD SAFEX) (6-F, 18-M; mean 
age=68.0, SD=T 1.0); and eighteen individuals were utilized in the non-exercise control 
group (8-F, 10-M; mean age=68.6, SD=8.1). For the second component of the current 
study, the non-exercise control group and individuals that did not complete the washout 
testing were removed from analysis. It was common for participants to complete a twelve 
week exercise session and then leave on holiday and be unavailable for washout testing. 
Thus, forty-nine individuals were used for analysis of the second component. One 
participant was removed from the aquatic group; three were removed from the aerobic 
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group; seven were removed from the strength group; and, twelve were removed from the 
PD SAFEX group. 
Interventions 
Each exercise program was administered 3 -times/week for 30 to 36 classes over 
10 to 12 weeks depending on whether the program was completed in the fall, winter, or 
spring (due to the holidays associated with the season). Non-exercise control participants 
were instructed to maintain their normal physical activity routine for a 12 week period. 
The aquatic exercise program was completed in a group setting over a one hour 
period. The exercise distribution over the hour was approximately 20 minutes of 
stretching and range of motion exercises on the pool side; 20 minutes of balance and 
strengthening exercises in a chest deep pool using the water as resistance; and 20 minutes 
of stretching and relaxation exercises seated on the pool edge with the feet in the water. 
The exercises were modified from a seniors program at the Baycrest Centre for Geriatric 
Care (Toronto, ON). 
The aerobic intervention had participants training in groups of four, with each 
participant using a BioStep® Semi-Recumbent Elliptical machine for 30 minutes per 
training session. The machine was primarily leg driven as participants exercised in a 
seated position. The movement pattern had the legs pushing forward, tracing an ellipse, 
as the arms moved simultaneously in a coordinated pattern similar to walking. For 
example, while pushing forward with the right leg, the left arm would also move forward 
while the right arm and left leg moved backwards. Each exercise session consisted of a 5 
minute warm-up, 20 minutes of aerobic training and a 5 minute cool-down. Exercise 
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intensity was maintained by achieving: (i) a pace of 50rpm, (ii) a heart rate between 60-
75% of age calculated max, and (iii) a Borg rating of perceived exertion (RPE) below 5 
on a 10-point scale. These criteria were monitored on a continual basis and recorded over 
the final two minutes of the aerobic training portion of an exercise session. If the heart 
rate and RPE were below the desired range for two consecutive sessions, resistance was 
increased. Participants began training at a level of 20 Watts and each progressive increase 
was approximately 15 Watts. 
The strength training program was a whole body workout that targeted the major 
muscle groups (chest, back, arms, abdominal muscles and legs) during each training 
session. The exercises were completed individually during a designated hour long period 
for the exercise group at a standard workout facility. Thus, it was a modified group 
setting as each exercise was completed individually while group members shared the 
exercise equipment. Three sets of 10-15 repetitions of each exercise were completed. As 
the strength training progressed, weight lifted was increased as participants were able to 
complete 3 sets of 14-15 repetitions, and weight lifted was maintained if participants 
were able to complete 10-12 repetitions. Each participant filled out a log of the weight 
lifted and number of repetitions which was inspected by a knowledgeable personal trainer 
who oversaw the training sessions and adjusted the weight lifted as necessary. Two 
YMCA training facilities were utilized to complete the strength training programs. The 
two groups were compared and found to have equivalent responses to the exercises and 
were combined into one strength training group for analysis. 
The sensory attention focused exercise (PD SAFEX) was completed in a group 
setting with approximately 10-15 participants, one head instructor and enough student 
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volunteers to maintain a 2:1 ratio of participants to assistants. The volunteers were senior 
undergraduate kinesiology students, many of whom were involved in a movement 
disorders class, and all received training in the proper execution of the exercise program. 
Volunteer training included instruction on common symptoms and behaviours associated 
with PD as well as a description of the key components of the PD SAFEx program for the 
volunteers to assist with. Each exercise class involved 20-30 minutes of non-aerobic gait 
exercises, using a 75 meter circuit, which focused on body coordination followed by 20-
30 minutes of sensory attention exercises utilizing standard office chairs (All Seating 
Corporation, Model No.3307) with latex Thera-bands® attached to the arm rests for 
resistance. The core component of the exercises was to have participants focus their 
attention on sensory feedback and awareness of their body in space. This was achieved 
by dimming the lights in the exercise room and requiring participants to complete the 
majority of the exercises with their eyes closed. Further, the instructor cued specific 
sensory feedback from each exercise and the volunteers reinforced the sensory feedback 
through verbal reminders and physically correcting improper body positioning. Each 
week the exercises became progressively more challenging to participants body 
coordination, balance and increased sensory feedback. 
While a complete description of each exercise is beyond the scope of the current 
manuscript a description of one of the gait exercises is provided to give further insight 
into how the aims of the PD SAFEX program were achieved. A main component of the 
gait exercises was coordinated movement patterns such as raising one leg to have the big 
toe touch the opposite knee, while simultaneously swinging the contralateral hand to 
contact the cheek/ear. For example, raise the right leg and have the right toe contact the 
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left knee, at the same time swing the left arm to have the left hand contact the left 
cheek/ear. Thus, a movement pattern similar to regular gait was required to complete this 
exercise properly. As participants' eyes were closed they were forced to utilize only 
tactile feedback from the contact between the toes and knee and the hand and cheek to 
complete the required movement. Finally, balance was challenged as single leg stance 
was required to bring the toes up to the knee. As the focus was not aerobic, volunteers 
ensured each participant moved as slowly as necessary to properly complete each 
component of the exercise. A more complete description of the PD SAFEX program has 
been described elsewhere (Sage & Almeida, In Press) and has been included in appendix 
A. 
Participants could have participated in multiple exercise interventions; however, 
to avoid the possible confounding effects of switching exercises, the current study 
utilized participants who completed their first exercise intervention or had a minimum 15 
week non-exercise period between the end of the first exercise program and the start of 
the next program (only one participant was in both the SAFE and aerobic groups). Non-
exercise control participants were utilized in analysis if the non-exercise period preceded 
any exercise intervention (three participants were in both the SAFE and control groups 
and three participants were in both the aerobic and control groups). All participants 
signed informed consent letters before beginning the study and this research was 
approved by the research ethics board at Wilfrid Laurier University. 
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Evaluation 
The primary outcome measure was a clinical assessment of Parkinsonian 
symptoms using the motor section of the Unified Parkinson's Disease Rating Scale 
(UPDRS) (Fahn, 1987). The UPDRS measures the symptoms of PD on using a five point 
scale with zero representing no symptoms present and four representing the most severe 
symptoms. Each item on the UPDRS represents specific symptoms of PD such as speech, 
tremor, rigidity, gait and postural stability. Thus, the UPDRS provides an assessment of 
global motor symptoms of PD. A certified and trained evaluator blinded to group 
assignment performed all UPDRS assessments while participants were on their peak 
dosage of Parkinsonian medication. Proper blinding of the clinician was achieved through 
testing participants from multiple exercise groups and non-exercise control participants 
on the same day in a random order. Participants were strictly instructed not to reveal their 
group assignment to the clinician during assessment. 
Statistical Analysis 
The first comparison utilized all eighty-nine participants and compared the four 
exercise groups with the non-exercise control group on their UPDRS scores. A group 
(aquatic vs aerobic vs strength vs PD SAFEX vs non-exercise) x time (pre-test vs post-
test) analysis of variance was performed to compare the different exercise interventions 
and the non-exercising control group. While the ANOVA did pass the assumption of 
homogeneity of variances, to control for potential differences at pre-test a percent change 
was calculated for each participant by subtracting the post-test score from the pre-test 
score and dividing by the pre-test score [(pre-test - post-test)/pre-test x 100%]. The 
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percent change standardized the UPDRS changes as each participants change due to 
exercise was compared to their individual pre-test level. The percent change was utilized 
in a one-way analysis of variance to determine if the five groups differed on their percent 
change. Statistical analysis followed intention to treat guidelines and significant main 
effects and interactions were followed up using Tukey's post-hoc criteria. 
The second comparison utilized the forty-nine participants that completed all 
three round of evaluation: pre-test, post-test and washout. An exercise group (aquatic vs 
aerobic vs strength vs PD SAFEX) x time (pre-test vs post-test vs washout) analysis of 
variance using overall UPDRS scores was performed to compare the four exercise 
groups. Again, the ANOVA did pass the assumption of homogeneity of variances, but 
three percent changes were calculated to control for potential differences at pre-test: i) 
(pre-test - post-test)/pre-test; ii) (post-test - washout)/pre-test; and iii) (pre-test -
washout)/pre-test. The percent change was utilized in a one-way analysis of variance to 
determine if the four groups differed. Statistical analysis followed intention to treat 
guidelines and significant main effects and interactions were followed up using Tukey's 
post-hoc criteria. 
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RESULTS 
The five groups were of a statistically similar mean age and mean years since 
diagnosis of PD. The aquatic group did not have any female participants and the PD 
SAFEX group had a larger number of males than females, the other three groups had 
nearly identical gender distributions. The strength training (mean=29.6) and non-exercise 
control group (mean=24.6) had significantly different baseline disease severity measured 
with the UPDRS. Table 1 provides a full breakdown of baseline participant 
demographics. 
Immediate Effects of Exercise 
A significant group by time interaction was found for UPDRS scores, (F(4,84) = 
4.60, p<.002) (Figure 1). Post-hoc revealed that both the PD SAFEX (pre-test = 27.2, 
post-test = 20.5) and strength training (pre-test = 29.6, post-test = 24.1) groups 
significantly improved their UPDRS scores from pre-test to post-test. Post-hoc revealed 
that at pre-test the strength training group (mean = 29.6, SD = 11.0) had significantly 
higher UPDRS scores than the non-exercise control group (mean = 24.6, SD = 9.3). The 
non-exercise control group witnessed an expected small yet insignificant increase in their 
UPDRS scores from 24.6 at pre-test to 25.1 at post-test. Comparison of the non-exercise 
control group to the exercise groups at post-test displayed that the PD SAFEX (mean = 
20.5, SD = 8.8) group had significantly less severe UPDRS scores than the non-exercise 
control group (mean = 25.1, SD = 9.3). 
The one-way ANOVA revealed that the five groups significantly differed on the 
percent change in UPDRS scores from pre-test to post-test (F(4,84) = 6.36, p<.001) 
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(Figure 2). Post-hoc revealed that the PD SAFEX (mean = 24.5%) and strength training 
(mean = 18.6%) had a larger percent improvement then the non-exercise control group 
(mean = -2.1%). The aquatic (mean = 12.0%) and aerobic (mean = 13.3%) groups did not 
significantly differ from the non-exercise control group. A full breakdown of results is 
provided in table 2. 
Lasting Effects of Exercise 
A significant time of test main effect was observed (F(2,90) - 14.3, p<.001) 
indicating that UPDRS symptom severity scores were decreased at post-test compared to 
both pre-test and washout. The group by time interaction approached significance 
(F(6,90) = 1.97, p<.078) as UPDRS scores appeared to be reduced at post-test for the PD 
SAFEX and strength training groups and the aerobic group appeared to have no change to 
their UPDRS scores at all three testing times. 
The percent change from pre-test to post-test one-way AN OVA narrowly missed 
significance (F(3,45) = 2.7, p<.057) suggesting that the PD SAFEx and strength groups 
appeared to have a greater percent improvement than the aquatic and aerobic programs. 
No significant differences were identified for the post-test to washout percent change 
(F(3,45) = 1.36, p<.267) or the pre-test to washout percent change (F(3,45) = 0.55, p<.65) 
comparisons. A full breakdown of results is provided in table 3. 
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DISCUSSION 
The focus of the current study was to compare four exercise strategies and a non-
exercise control group on their symptomatic benefit in PD. The first comparison of pre-
test to post-test scores for the four exercise groups and the non-exercise control group 
suggested that strength training and PD SAFEX were the best strategies as they resulted in 
significant improvement on UPDRS scores. Additionally, the PD SAFEX intervention 
(24.5%) had the largest percent improvement followed by the strength training group 
(18.6%). Similarly, when washout testing was included in analysis both the strength 
training and PD SAFEX groups yielded the greatest symptomatic benefit. These results 
were partially in line with the hypothesis, since the PD SAFEX group did realize the 
greatest benefit of the exercise program along with the strength training group. The PD 
SAFEX intervention may have improved the sensorimotor integration deficit in PD while 
strength training may have improved neuromuscular transmission, both leading to 
improved PD symptoms. 
The non-exercise control participants provided a glimpse into the natural 
progression of PD and were an important group to compare the exercise groups with. A 
publication bias may exist in PD exercise rehabilitation literature as non-successful trials 
are not reported (Deane et al., 2002). However, as PD is a progressive disease, 
maintenance of pre-test disease severity could be considered a success. An adequate 
control group allows for a more accurate determination of beneficial exercise 
interventions and is a strength of the current study. Interestingly, only the PD SAFEX 
group had significantly improved their UPDRS symptom severity scores to a level below 
the non-exercise control group at post-test. This result must be interpreted cautiously as 
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the strength training group, which saw a significant UPDRS improvement following 
exercise, had a significant pre-test UPDRS score five points higher than the control 
group. Thus, a large improvement for the strength training group and a substantial decline 
for the control group were required for a significant difference to appear between these 
groups at post-test. Nevertheless, the specific comparison of UPDRS scores between the 
PD SAFEX group, which was two and a half points higher at pre-test, and the non-
exercise control group is particularly intriguing as the PD SAFEX program was four and a 
half points lower than the control group at post-test. 
While the groups did not begin at equivalent disease severities the percent change 
calculations was also a strength of the current study, since it allowed adequate 
comparisons between the groups to be made. The percent change standardized the effects 
of the exercise intervention by comparing each participant's UPDRS score change to 
their own pre-test level. Further, the percent change calculation provides a different 
dimension for comparison than the raw score analysis. For example, a participant with a 
pre-test UPDRS of 50 that lowers their score by five points (10%) is very different from a 
participant with a pre-test UPDRS score of 15 that lowers their score by five points 
(33.3%). The percent change analysis of the current study demonstrated that the aerobic 
and aquatic groups were not statistically different than the non-exercise control group, 
indicating that these exercise strategies are likely not advisable for individuals with PD. 
Further, the percent change analysis allowed for an important comparison to be made 
between the strength training group and non-exercise control group, which revealed that 
the strength training had a significantly greater percent change than the control group. 
Similarly, the PD SAFEX program had a greater percent change than the control group. 
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The end result of the pre-test to post-test percent change comparison was identical to the 
raw score analysis in that the PD SAFEX and strength training programs appear to have 
the greatest symptomatic benefit. 
Including a six week no intervention washout period allows for assessment of the 
lasting effects of exercise. Although, neither the UPDRS score interaction or any of the 
percent change comparisons reached statistical significance they did reveal interesting 
responses to the exercise interventions. The pre-test to post-test percent change was 
nearly identical to the percent change comparison that included all participants, which 
suggests that even though a large number of participants were removed from the washout 
testing analysis the participants included were representative of their respective exercise 
groups. Post-test to washout testing percent change was between -18 to -20 percent for 
the aquatic, strength training and PD SAFEx groups, indicating that these three groups 
saw an increase in their UPDRS scores from post-test to washout. While an increase in 
scores was expected for the strength training and PD SAFEX groups as they had the 
largest improvement at post-test; the large increase (-18.7 percent change) in the aquatic 
group from post-test to washout after only a 10% improvement from pre-test to post-test 
further suggests that the aquatic exercise program was not beneficial for individuals with 
PD. Comparison of the pre-test to washout percent changes also suggests that aquatic 
exercise is not beneficial for PD. While not statistically significant a -8 percent change 
was observed in this group while the other three exercise groups ranged from 1.7 to 4.9 
percent improvement. Thus, the percent change analyses suggest that PD SAFEX and 
strength training provided the most direct benefit of exercise and these benefits appeared 
to be maintained following the non-exercise washout period. 
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The current study was internally strengthened by having participants exercise for 
equivalent lengths of time and ensuring the same properly blinded clinician performed all 
UPDRS assessments. Nevertheless, a few limitations are worth addressing. The aerobic 
exercise utilized a specialized exercise machine that had theoretical potential to benefit 
individuals with PD; particularly the coordinative movements of the arms and legs were 
identical to that of gait which is disturbed in PD. However, this novel aerobic 
intervention has only been investigated once previously (Sage & Almeida, In Press) and 
this limits the comparison of the results of the aerobic intervention to previous aerobic 
exercise interventions using more common techniques such as walking on a treadmill 
(Cakit et al., 2007; Miyai et al, 2000; Miyai et al., 2002) or in the external environment 
(Lokk, 2000; Sunvisson et al., 1997). It is worth noting that previous work by Sage & 
Almeida involved a more comprehensive analysis of this aerobic intervention and 
concluded that it was not the optimal exercise method for individuals with PD (Sage & 
Almeida, In Press). A second limitation was the removal of a large number of 
participants, particularly from the PD SAFEX group, from the washout testing analysis. 
However, the pre-post comparisons of the UPDRS scores and the pre-test to post-test 
percent change were nearly identical to the first analysis indicating that the participants 
included in the washout analysis were representative of their respective group. Thus, 
aside from a reduction in power due to the smaller sample sizes, the removal of 
participants for the second analysis did not likely appreciably alter the results. 
In a recent review, Deane et al. suggested a number of important criteria to 
include in PD exercise research to address the shortcomings of previous research. 
Amongst their suggestions were: use a large number of patients, use an adequate placebo 
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therapy, follow patients after the exercise is stopped, and use disease specific measures 
(Deane et al., 2002). The current study addressed all of these important suggestions, 
which adds to the strength of the results. The group sizes were large, as even the twelve 
participants in the aquatic program exceeded a number of commonly cited research 
studies (Marchese, Diverio, Zucchi, Lentino, & Abbruzzese, 2000; Miyai et al., 2000). 
The current study also utilized a non-exercise control group, followed participants 
beyond the end of the exercise program and used the current gold standard for assessing 
PD symptoms, the UPDRS. 
While the current study alone is not sufficient to make final conclusions on the 
optimal exercise strategy for individuals with PD, the methodological strength of the 
current study is an important contribution to the search for the optimal exercise strategy 
and suggests that PD SAFEX and strength training are more beneficial for individuals 
with PD than aerobic or aquatic exercise. 
Table 1 - Baseline participan 
Aquatic 
Aerobic 
Strength 
PD SAFE* 
Control 
Gender 
0-F, 12-M 
8-F, 9-M 
9-F,9-M 
6-F,18-M 
8-F, 10-M 
t demographics 
Age 
63.1 (9.2) 
65.8 (9.9) 
68.7 (8.3) 
68.0(11.0) 
68.6(8.1) 
for the five groups 
Years Since 
Diagnosis 
7.7 (6.4) 
3.8 (3.9) 
5.7 (4.0) 
5.1 (4.5) 
3.2 (2.8) 
UPDRS 
28.5 (10.0) 
26.9(11.8) 
29.6(11.0) 
27.2(10.2) 
24.6 (9.3) 
UPDRS, Unified Parkinson's Disease Rating Scale; PD SAFEX, sensory attention focused 
exercise; Control, non-exercise control group 
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Table 2 - Pre-test and post-test mean (±standard deviation) of Unified Parkinson's 
Disease Rating Scale (UPDRS) scores and percent change of the four exercise groups and 
the non-exercise control group. Percent change calculated as (pre-test - post-test)/pre-test 
x 100% 
Group 
Aquatic 
PD SAFEX 
Strength 
Aerobic 
Control 
Pre-test (UPDRS Score) 
28.5 (10.0) 
27.2(10.2) 
29.6(11.0) 
26.9(11.8) 
24.6 (9.3) 
Post-test (UPDRS Score) 
25.0(8.7) 
20.5 (8.8) 
24.1 (9.6) 
23.4 (8.7) 
25.1 (9.3) 
Percent Change (%) 
12.0(15.2) 
24.5 (20.8) 
18.6(17.0) 
13.3(16.5) 
-2.1 (24.7) 
PD SAFEX, Sensory Attention Focused Exercise; Control, non-exercise control group 
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Table 3 - Mean (±standard deviation) of Unified Parkinson's Disease Rating Scale 
(UPDRS) scores, including washout and percent change of the four exercise groups. 
Percent change calculated as (test 1 - test 2)/pre-test x 100% 
Group Pre-test 
(UPDRS 
Score) 
Post-test 
(UPDRS 
Score) 
Washout 
(UPDRS 
Score) 
Pre-test 
to Post-
test (% 
Change) 
Post-test 
to 
Washout 
(% Change) 
Pre-test 
to 
Washout 
(% Change) 
Aquatic 29.3(10.0) 25.9 (8.6) 31.5(11.2) 10.7(15.9) •18.7(16.5) -8.0(15.5) 
PD SAFEX 24.7 (9.7) 19.2(10.0) 22.7 (6.4) 23.6(23.3) -20.3(38.1) 3.2 (27.0) 
Strength 28.9(12.7) 23.1 (10.3) 27.8(12.0) 19.9(16.7) -18.1 (27.8) 1.7(25.2) 
Aerobic 26.5(12.8) 23.7(9.6) 22.8(7.9) 5.5(15.3) -0.5(28.7) 5.0 (34.0) 
PD SAFEX, Sensory Attention Focused Exercise; Control, non-exercise control group 
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Figure 1 - Comparison of UPDRS scores before exercise began (pre-test) and 
immediately following the end of the intervention (post-test). * denotes significance at 
p<.01. # denotes significance at p<.05. 
PD SAFEX, Sensory Attention Focused Exercise; Control, non-exercise control group. 
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Figure 2 - Comparison of percent change on the Unified Parkinson's Disease Rating 
Scale following exercise, calculated as pre-test - post-test/pre-test x 100%. Note that 
positive percent change indicates improved Parkinson's disease symptoms. * denotes 
significance at p<.001. 
PD SAFEx, Sensory Attention Focused Exercise; Control, non-exercise control group. 
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CHAPTER 4 
THE EFFECT OF INCREASED SENSORY FEEDBACK DURING EXERCISE IN 
PARKINSON'S DISEASE 
ABSTRACT 
Deficits integrating and utilizing proprioceptive information especially during 
self-motion have been identified in Parkinson's disease (PD) (Almeida et al., 2005). The 
current study evaluated the effect of increased attention on sensory feedback during 
exercise. Two twelve week long exercise programs that differed only in the presence (PD 
SAFEX) or absence (non-SAFE) of increased attention focused on sensory feedback were 
compared symptomatically using the Unified Parkinson's Disease Rating Scale 
(UPDRS). Participants were assessed before the start of the exercise program (pre-test), 
immediately following the 12 week program (post-test) and after a minimum six week 
non-exercise washout period (washout). Secondary outcome measures included the 
Timed-Up-and-Go (TUG), Grooved Pegboard (GP) and velocity and step length of self-
paced gait. The UPDRS symptom severity scores revealed that only the PD SAFEx 
program significantly improved PD symptoms and that gains were maintained following 
a six week non-exercise washout period. The TUG, GP, velocity and step length did see 
some improvement following exercise but no differences were observed between the 
exercise groups. The results suggest that symptom specific measures such as the UPDRS 
are a critical component of exercise rehabilitation research, to ascertain whether benefits 
of exercise are general musculoskeletal benefits or disease specific neurological benefits. 
Further, increased focus on sensory feedback appears to benefit exercise programs as it 
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resulted in improved PD symptoms that were maintained after the intervention was 
stopped. 
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INTRODUCTION 
Parkinson's disease (PD) is a disorder of the basal ganglia caused by a 
deterioration of dopamine producing neurons in this area; it is estimated that 70% of 
these neurons are lost before motor symptoms are detectable (Wolters & Francot, 1998). 
The physical symptoms of PD include tremor, rigidity, postural instability, bradykinesia 
(slowness of movement), and akinesia (absence of movement) (Guttman, Kish, & 
Furukawa, 2003). To combat PD symptoms numerous exercise approaches such as 
treadmill walking (Miyai et al., 2000; Miyai et al., 2002) or traditional physical therapy 
(Ellis et al., 2005) have been attempted with conflicting results (de Goede, Keus, 
Kwakkel, & Wagenaar, 2001; Deane et al., 2002). An important consideration is that 
perhaps, these approaches are not the ideal exercise model as they were designed based 
on the musculoskeletal PD deficits such as rigidity or altered gait and not the underlying 
neurological deficits causing the visible motor symptoms. 
More recently exercise strategies that have attempted to improve disease specific 
symptoms and movement deficits in PD have been investigated and shown promising 
results. Cueing is the primary symptom specific strategy that has been employed in rehab 
settings based on research displaying that auditory and visual cues can improve the 
disturbed gait present in PD (Lewis, Byblow, & Walt, 2000; M. E. Morris, Iansek, 
Matyas, & Summers, 1996; Rubinstein, Giladi, & Hausdorff, 2002). The largest study 
involving 153 participants trained using visual and auditory cues found increases in 
velocity, step length and posture and gait, measured as a subset of the Unified 
Parkinson's Disease Rating Scale (Nieuwboer et al., 2007). Similar success was found by 
Thaut et al. where rhythmic auditory stimulation (synchronized beats to music) during 
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gait exercises was found to increase cadence, velocity and stride length following 
exercise (Thaut et al., 1996). Further, del Olmo et al. also found improvements in 
spatiotemporal aspects of gait following exercises paced by a metronome (del Olmo & 
Cudeiro, 2005). Two main limitations were present in this research. The first was that the 
exercise and outcome measures used were primarily gait focused and as suggested in a 
review by Deane et al., specific impairments such as decreased step length can be easily 
altered but may not benefit a patient's day to day activities (Deane et al., 2002). The 
second limitation was that only Nieuwboer et al. (2007), who used a subset of the 
UPDRS, utilized any clinical measure of the symptoms of PD. Thus, it was difficult to 
ascertain whether the mobility benefits resulting from cueing exercise were in fact 
disease specific symptomatic gains or only very specific mobility gains. Utilizing PD 
symptom specific measures such as the UPDRS should be incorporated as an outcome 
measure in exercise rehabilitation research to allow evaluation of exercise trials in a 
disease specific symptom manner. 
Few studies have addressed the previously identified limitations. The del Olmo et 
al. group built on their previous research by examining changes using positron emission 
tomography (PET) and found cortical changes after cueing exercise that suggested 
cortical reorganization to bypass the defective basal ganglia (del Olmo, Arias, Furio, 
Pozo, & Cudeiro, 2006). Another approach taken by Marchese et al. utilized a cued and 
non-cued group and a clinical measure of PD symptoms, the UPDRS. Both groups were 
found to benefit from the exercise, however, following a six-week non-exercise period 
only the cued group retained the benefits of the exercise program (Marchese, Diverio, 
Zucchi, Lentino, & Abbruzzese, 2000). These limited results point to potential benefit of 
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sensory cues, however, further well designed research into the benefit of sensory based 
PD exercise rehabilitation programs is needed. 
The current study builds on the previous work completed at our research center 
which identified functional improvements following Sensory Attention Focused Exercise 
(PD SAFEX) (Sage & Almeida, In Press). Research has suggested that individuals 
suffering from PD have a deficit in their ability to integrate and utilize sensory, 
specifically proprioceptive feedback (Almeida et al., 2005; Jacobs & Horak, 2006). This 
deficit may stem from the dysfunctional basal ganglia which has been suggested to play 
an important role in the integration of proprioceptive feedback during movement 
(Almeida et al., 2005). The PD SAFEX program was designed to help guide participants 
to focus on and utilize proprioceptive feedback, thus, improving awareness of self motion 
during the performance of each exercise. To obtain this goal, exercises were done in the 
dark, with eyes closed and instructions keyed participants' attention to specific sensory 
markers (i.e. 'feel your toes touch your knee') needed to effectively complete each 
exercise. 
The purpose of the current study was to evaluate whether increased attention on 
sensory and proprioceptive feedback during the PD SAFEX program has a specific 
influence on the symptoms of PD. As such, a modified PD SAFEX program that involved 
identical exercises but lacked the increased attention on sensory and proprioceptive 
feedback (non-SAFE) was compared to the PD SAFEX intervention to determine the 
effect of increased sensory feedback attention in PD. Symptom specific measures 
(UPDRS) and traditional measures (spatiotemporal aspects of gait, timed-up-and-go, and 
grooved pegboard) were used to improve on deficits identified in previous exercise 
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rehabilitation literature and to evaluate the effectiveness of the exercise programs on a 
wide range of PD specific symptomatic deficits. Three testing periods were used 
including a pre-test before the exercises began, a post-test administered immediately 
following the end of the exercise program and a minimum six week non-exercise 
washout period. The washout period was of particular importance because it allowed for 
an evaluation of the lasting effects of the exercise programs and provided insight into 
whether improvement on outcome measures was due to increased musculoskeletal fitness 
or neurological improvements. 
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METHODS 
Participants 
From September 2006 to August 2007, the PD SAFEX and non-SAFE exercise 
programs were administered simultaneously at the Movement Disorders Research and 
Rehabilitation Centre (MDRC) at Wilfrid Laurier University over three 12-week sessions 
with a six week non-exercise washout period separating each session. While 48 
participants were involved, the current study examined the 26 participants with idiopathic 
PD who completed either the PD SAFEX (n=13; mean age=66.1, UPDRS=24.7) or the 
non-SAFE (n=13; mean age=66.8, UPDRS=20.2) program and all three rounds of testing 
(pre-test, post-test, washout). Since some participants were involved in multiple exercise 
sessions (fall, winter, summer) the 26 participants used in the current study were 
participating in their first exercise session at the MDRC. The majority of participants 
excluded from the current study were eliminated because they missed a testing session; 
often due to travel requirements (i.e. exercised during the fall session and then went down 
south for the winter and missed washout testing). 
All participants had a diagnosis of PD with no other major neurological or 
psychological problems. All medication and supplementary physical activity was 
unaltered for the duration of the study such that the only addition to a participant's 
regular schedule was the exercise program they were administered. This research was 
approved by the research ethics board at Wilfrid Laurier University and all subjects 
signed informed consent forms before commencement of the study. 
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Exercise Interventions 
Participants were randomly assigned to either participate in the full PD SAFEX 
program or the non-SAFE program. Both exercise interventions required participants to 
attend three times per week for approximately one hour, with the main difference 
between the programs being the lack of sensory focus in the non-SAFE program. A more 
complete description of the PD SAFEX program has been published previously (Sage & 
Almeida, In Press) and is provided in appendix A. Briefly, however, both programs were 
group settings with approximately fifteen participants, one instructor and enough student 
volunteers (senior undergraduate students at WLU trained in proper administration of the 
exercise program) to maintain a 2:1 ratio of participants to volunteers. The volunteers 
were present to ensure participants' safety and to reinforce the sensory cues for the 
participants. There were approximately 30 minutes of non-aerobic gait exercises followed 
by 30 minutes of exercises using office chairs (All Seating Corporation, Model No.3307) 
with latex Thera-bands® attached to the arm rests for light resistance. The PD SAFEX 
exercises were designed to have participants focus on their sensory feedback by dimming 
the lights, having participants close their eyes, and cueing them to specific portions of the 
exercises. The non-SAFE program mirrored the PD SAFEX program, with the exception 
of the focus on sensory feedback as the lights were on, participant's eyes were open, and 
the instructions did not cue participants to sensory feedback. 
An example of the instruction of the same exercise provided to both programs 
may highlight the different aims of the two programs. A simple hamstring stretch was 
performed in a seated position with the foot rested on the seat of the chair and the arms 
pulling the leg in to the chest. The non-SAFE program completed the exercise with eyes 
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open, lights on and received general instruction to bring their foot onto the chair and pull 
the leg towards the chest. The PD SAFEX program completed the exercise with their eyes 
closed and lights off forcing them to rely only on tactile and proprioceptive feedback. 
The instructions were to maintain contact between the calf and the front edge of the chair 
while raising the leg up. Once the heel reached the seat of the chair, the foot was rested 
on the seat of the chair and the leg pulled into the chest. While holding the stretch 
participants were instructed to focus on the feeling of the stretch in their hamstring. On 
the second set of the stretch, participants were instructed to ensure the feeling of the 
stretch was identical to the first set, which provided feedback that they were performing 
the exercise properly. The different instructions and procedures to complete a simple calf 
stretch display the different focuses of the PD SAFEX and non-SAFE exercise programs. 
Evaluation 
Participants were evaluated at three separate time periods: (i) before commencing 
the exercise intervention (pre-test); (ii) immediately following the last exercise session 
(post-test); (iii) a minimum of six weeks following the end of the exercise intervention 
(washout). 
The primary outcome measure was a clinical evaluation consisting of the Unified 
Parkinson's Disease Rating Scale motor section (UPDRS) (Fahn, 1987) which measured 
symptoms of PD on a five point scale with four representing the most severe symptoms 
and zero representing no symptoms present. The UPDRS was administered at 
participants' peak anti-Parkinsonian medication dosage by a trained evaluator blinded to 
participants' group assignment. Blinding was achieved by testing participants from both 
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exercise groups in random order on the same day as participants from other research 
projects and instructing participants not to reveal group assignment to the clinician. The 
UPDRS motor section was further broken down into subsets incorporating all items with 
both a left and right side component to assess changes to the most and least affected body 
side to provide insight into neurological changes corresponding to the most and least 
denervated side of the basal ganglia. 
Upper limb motor control was assessed using the Grooved Pegboard (GP) 
(Lafayette Instruments, Lafayette, IN). Participants completed two trials with each hand 
following a procedure previously outlined (Bryden & Roy, 2005). Each trial consisted of 
both a place phase where 25 grooved pegs were placed into key shaped holes and a 
remove phase where the pegs were subsequently removed using the same hand. The order 
of limb testing was started randomly and then alternated between the limbs until both 
limbs had completed the procedure twice. All participants were self reported right-handed 
and the place and remove phases of the GP were analyzed based on the most and least 
affected body side, as identified using the UPDRS scores at pre-test. Participants 
completing the GP in more than four minutes did not complete a second trial and 
participants unable to complete the grooved pegboard in five minutes were stopped, a 
count of pegs completed was taken, and the remove phase was not completed. This was 
done to avoid the frustration associated with spending twenty to thirty minutes 
completing the GP. To include as many participants in analysis as possible an average 
rate of time(s) per peg for the two trials was averaged for each participant and used in 
statistical analysis. Three participants were removed from analysis of the remove phase 
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using the affected limb and one participant was removed from analysis of the remove 
phase using the non-affected limb due to failure to complete the task. 
Gait was measured in a functional task using two trials of the Timed-Up-and-Go 
(TUG), which has been shown to be a reliable outcome measure in PD (S. Morris, 
Morris, & Iansek, 2001). Each trial had participants' begin from a seated position, stand 
up, walk three meters, turn around, return to the chair and sit down as quickly as possible. 
Spatiotemporal aspects of gait including velocity and step length were measured using 
five trials of self-paced gait over a four meter pressure sensitive GAITrite® carpet. Each 
trial began a minimum of two paces before the carpet and the participant continued 
walking a minimum of two paces after measurement ceased to ensure that acceleration 
and deceleration were not included in measurement. 
Statistical analysis was completed using Statistica® software with an alpha level 
of 0.05. Each outcome measure was analyzed using group (PD SAFEX vs non-SAFE) by 
time (pre-test vs post-test vs washout) analysis of variance. Significant ANOVA's were 
followed up using Tukey's HSD post-hoc procedure. The post-hoc comparisons of 
particular importance were the pre-test to post-test and post-test to washout comparisons, 
which indicate the immediate and lasting effect of the exercise programs respectively. 
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RESULTS 
The two groups were not significantly different on their mean age, years since 
diagnosis or disease severity (measured with the UPDRS). Baseline demographics of the 
two exercise groups are outlined in table 1. A complete breakdown of all results is 
provided in table 2. 
Clinical Evaluation 
The UPDRS symptom severity score analysis revealed a significant group by time 
interaction (F(2,48) = 3.62, p<.035) figure 1. Post-hoc indicated that only the PD SAFEX 
group improved their UPDRS scores at post-test compared to pre-test (p<.035) and 
maintained the improvements from post-test to end of washout (p>.05). The non-SAFE 
group did not appreciably alter their UPDRS scores following exercise, however, after 
the washout period the UPDRS scores were significantly higher (i.e. symptoms 
worsened) than at post-test (p<.035). 
Side affected UPDRS analysis identified main effects of time for both the affected 
(F(2,48) = 8.90, p<.001) and non-affected (F(2,48) = 5.23, p<.01) sides of the body, 
figure 2a & 2b. On the affected side of the body the post-test significantly improved 
compared to both the pre-test and washout, suggesting that symptom severity was 
decreased following exercise. The non-affected side of the body revealed no significant 
UPDRS change from pre-test to post-test but scores were significantly higher (i.e. 
symptoms worsened) at washout. A group by time interaction for the affected side 
narrowly missed significance (F(2,48) = 3.09, p<.055) hinting that the PD SAFEX 
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program was associated with greater improvements, since UPDRS scores from pre-test to 
post-test improved by 27.4% while the non-SAFE had only improved by 4.3%. 
Upper Limb Motor Control 
Both the affected (F(2,42) = 5.62, p<.007) and non-affected (F(2, 46) = 13.07, 
p<.001) sides of the body displayed main effects of time for the remove phase of the GP 
indicating that post-test had a significantly faster rate (time/peg) than the pre-test, and 
that this improvement was maintained after the washout period (see figure 3a & 3b). The 
place phase of the grooved pegboard did not reveal any significant effects or interactions 
on either the affected or non-affected sides of the body. 
Gait 
A significant main effect of time for the TUG was found (F(2,48) = 4.69, p<.014) 
demonstrating that gait was significantly faster at post-test (compared to pre-test) and that 
these improvements were maintained after the washout period (see figure 4). 
Step length also revealed a main effect of time (F(2,48) = 3.28, p<.046) with a 
significantly increased step length at post-test compared to both pre-test and washout. 
Velocity approached significance for a main effect of time (F(2,48) = 2.82, p<.069) with 
participants appearing to have increased velocity at post-test compared to pre-test. 
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DISCUSSION 
The aim of the current study was to determine the effect of increasing attention to 
sensory feedback during exercise rehabilitation. Two identical exercise interventions 
were administered, differing only in the presence (PD SAFEX) or absence (non-SAFE) of 
focus on sensory feedback. As hypothesized, the increased focus on sensory feedback in 
the PD SAFEX program had the greatest influence on the clinical measure of PD 
symptoms (UPDRS), which was maintained following six weeks of inactivity. These 
findings are similar to the findings of Marchese et al. who utilized a comparable study 
design and found that two similar exercise programs, differing only in the presence or 
absence of sensory cues, displayed improved UPDRS symptom severity scores. 
However, only the sensory cued group maintained the improvements following six weeks 
without the exercises (Marchese et al., 2000). Interestingly, in the current study, all other 
changes as a result of exercise, including improved GP remove phase, TUG, and step 
length were main effects suggesting that both exercise programs were able to positively 
affect these measures. 
Clinical (UPDRS) Outcomes 
The primary outcome measure (clinical assessment of PD symptoms using the 
UPDRS) was the only outcome measure to reveal group differences through a group by 
time interaction. While participants were randomly assigned to groups and there was not 
a significant difference in UPDRS scores at pre-test, the non-SAFE group (mean = 20.19) 
was four points lower than the PD SAFEX group (mean = 24.73). Thus, it could be 
suggested that the PD SAFEX group had a larger capacity to improve their UPDRS motor 
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scores than the non-SAFE group. Examining UPDRS scores in more depth demonstrates 
that the PD SAFEX group improved their scores by 22%, while the non-SAFE group only 
improved theirs by 5% from pre-test to post-test. Previous research involving the PD 
SAFEX program also displayed similar results as 18 individuals with PD improved their 
UPDRS scores from 22.5 to 16.9, or 25% following 12 weeks of exercise (Sage & 
Almeida, In Press). Thus, the results of the current study were expected as they replicated 
findings previously reported. Interestingly, at post-test, both groups had identical UPDRS 
scores of 19.2 yet following the six week non-exercise period the non-SAFE groups mean 
UPDRS score had significantly worsened by 5.5 points while the PD SAFEX group 
maintained some of the benefits of exercise as their mean score insignificantly increased 
by only 3.42 points. Thus, the increased attention on sensory feedback present in the PD 
SAFEX program appears to benefit symptom severity of PD with improved symptoms 
maintained after the exercise was stopped. 
Changes Associated with Side Affected 
While the UPDRS motor scores revealed between group differences, the subsets 
corresponding to the affected and non-affected body sides did not. While only 
approaching statistical significance, the PD SAFEX group had greater improvement on the 
affected side in response to the exercises, witnessed by improvements of 27.4% and 
15.0% compared to 4.26% and 4.54% for the non-SAFE group on the affected and non-
affected sides of the body respectively. The improved scores in the PD SAFEX group may 
have driven the main effect; however, the group sizes may not have been large enough to 
display a significant interaction. These results were interesting, and to the best of the 
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author's knowledge the current study was the first to use this subset as an outcome 
measure and further exploration in future research is needed. 
Affected vs. non-affected side related symptomatic changes may be of greater 
importance than overall UPDRS change, since the comparison provides a clinical 
measure of the functioning level of the most and least denervated basal ganglia. Thus, the 
comparison will aid in determining the influence of exercise on different levels of 
dopaminergic neuronal denervation. Evaluating the influence of exercise on differing 
functional levels of the basal ganglia is important as previous rodent models induced with 
chronic PD suggested that at more severe disease progressions the mice were able to 
improve cardiovascular and musculoskeletal function but unable to improve neurological 
function following exercise (Al-Jarrah et al., 2007). Conversely, rats and mice induced 
with mild PD were able to improve neurological function, witnessed by a sparing of 
striatal dopamine, following exercise (Tillerson, Caudle, Reveron, & Miller, 2003). Thus, 
continuing to compare PD symptoms on the most and least affected body sides may 
provide an indication of neurological changes in the basal ganglia and aide in 
determining the influence of exercise on different levels of pre-exercise basal ganglia 
functioning. 
Changes associated with affected side were not identified through the grooved 
pegboard (GP), since neither group improved their time on the place phase and both 
groups improved their time on the remove phase for both affected and non-affected body 
sides. The place phase is a visuo-motor task while the remove phase is more a measure of 
motor speed (Bryden & Roy, 2005). As the participants in the current study were 
primarily older individuals, perhaps, the place task was too demanding for them. This is 
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supported by the observation that six participants (approximately 25%) required more 
than four minutes to complete the task or were unable to complete it. However, as the 
place phase analysis included all participants using a time per peg rate, and the 
participants that took longer to complete the task had a greater capacity to improve and 
positively influence the group results, it is more likely that neither exercise program was 
able to appreciably improve fine visuo-motor control. The remove phase does not require 
the same accuracy demands and both exercise groups did improve their rate on the 
remove phase indicating improved upper limb motor speed. Specific to PD symptoms the 
remove phase may be an indicator of improvement in one of the cardinal symptoms of 
PD, bradykinesia (slowness of movement) and thus the results suggest that both exercise 
programs improved upper limb bradykinesia. Since a number of exercises in both 
interventions required fine control of limb position, perhaps, individuals were able to 
improve upper limb movement efficiency, as suggested by the decreased time taken to 
remove the pegs. 
Analysis of Gait 
Locomotion was improved in both groups following exercise, supported by the 
main effect of time for the TUG. These results may be relevant to PD symptoms as the 
TUG specifically evaluates motor impairment issues that are commonly associated with 
PD such as sit to stand, initiation of gait, and dynamic balance while turning. Thus, both 
exercise programs improved locomotion and motor impairment following exercise and of 
further interest, the benefits were maintained in both groups following the six week non-
exercise period. 
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The improvements in gait following exercise were minor, as the significant main 
effect of step length at post-test was the result of a two cm increase, and no group 
differences were identified. However, the combined increases in velocity and step length 
are suggestive of a more normalized gait pattern. Minimal improvements were not 
unexpected as neither exercise program had a specific focus on gait. Further, specific 
impairments such as spatiotemporal aspects of gait have been shown to be easily 
influenced but are suggested to be inconsequential to a patients day to day life (Deane et 
al., 2002). Thus, the minor gait improvements identified in the current study are 
secondary as the focus was on a global improvement of PD symptoms. 
Conclusion 
The main effects of time observed in the objective outcome measures including 
the TUG, GP, and self-paced gait did not reveal any group differences since no 
significant group by time interactions were found. This suggests that the specific 
exercises of the intervention have the capacity to improve many movement 
characteristics and potentially functional outcomes (which may represent functional 
abilities in the home environment). Additionally, increased focus on sensory feedback in 
the PD SAFEX intervention led to an additive benefit in terms of decreased motor 
symptoms. Thus, the combined improvements on the objective measures and the UPDRS 
witnessed in the PD SAFEX program are more disease specific and display the benefit of 
increasing focus on sensory feedback in an exercise rehabilitation intervention. 
An additional strength of the current study was the continued evaluation of 
participants following a non-exercise washout period. The lasting effects in the PD 
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SAFEX group on the UPDRS suggests that the improvements following exercise with 
increased focus on sensory feedback are not simply musculoskeletal but the result of 
improved neurological functioning. While the exact mechanism behind the improved 
motor symptoms in PD is unknown two speculative mechanisms are: i) new pathways 
were formed in the brain to bypass the dysfunctional basal ganglia, or ii) The increased 
sensory feedback traveling through the basal ganglia is resulting in improved functioning 
of the remaining dopaminergic neurons. While the exact mechanism behind the improved 
motor symptoms of PD remains unknown, of more importance is the fact that increased 
attention on sensory feedback in the PD SAFEX program resulted in lasting symptomatic 
improvements. 
The main difference between the two exercise programs was the focused attention 
on sensory feedback. Increased focus on sensory feedback in the PD S AFEX group 
resulted in improved clinical symptoms, which were maintained after exercise ceased, 
while the non-SAFE group did not realize the same symptomatic benefits. As the primary 
focus was on global improvement in PD symptoms the results do suggest that increased 
attention on sensory, specifically proprioceptive, feedback is a beneficial addition to 
exercise programs for individuals with PD. 
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Table 1 - Mean (±standard deviation) baseline participant demographics for the two 
groups ^ _ _ _ _ _ _ ^ 
Group 
PD SAFEX 
non-SAFE 
Gender 
F-3.M-10 
F-6, M-7 
Age 
66.1(11.3) 
66.8 (9.0) 
Years Since 
Diagnosis 
4.2 (4.3) 
3.2 (2.9) 
UPDRS 
24.7 (9.7) 
20.2 (7.6) 
UPDRS, Unified Parkinson's disease rating scale; SAFE, sensory attention focused 
exercise 
Table 2 - Mean (±standard deviation) of outcome measures that revealed significant 
main effects resulting from Sensory Attention Focused Exercise (PD SAFEX) and non-
SAFE. 
Measure 
UPDRS (Score) 
UPDRS Affected Side (Score) 
UPDRS Non-Affected Side 
(Score) 
Grooved Pegboard Affected 
Side Remove Phase (sec/peg) 
Grooved Pegboard Non-
Affected Side Remove Phase 
(sec/peg) 
Timed-Up-and-Go (seconds) 
Step Length (cm) 
Velocity (cm/sec) 
Test 
Pre-test 
Post-test 
Washout 
Pre-test 
Post-test 
Washout 
Pre-test 
Post-test 
Washout 
Pre-test 
Post-test 
Washout 
Pre-test 
Post-test 
Washout 
Pre-test 
Post-test 
Washout 
Pre-test 
Post-test 
Washout 
Pre-test 
Post-test 
Washout 
PD SAFEX 
24.7 (9.7) 
19.2(10.0) 
22.7 (6.4) 
10.4 (2.6) 
7.5 (2.8) 
9.8 (3.3) 
5.7 (2.4) 
4.8 (2.8) 
6.1 (3.1) 
1.4(0.2) 
1.0(0.2) 
1.1 (0.2) 
1.2(0.3) 
1.0(0.3) 
1.0(0.2) 
8.0 (2.6) 
7.6 (3.2) 
7.6 (2.7) 
61.4(9.4) 
61.8(9.1) 
61.2(8.1) 
121.2(19.6) 
122.3 (18.3) 
121.2(15.7) 
Non-SAFE 
20.2 (7.6) 
19.2 (9.3) 
24.7 (7.6) 
10.0(2.4) 
9.5 (2.7) 
11.8(3.3) 
4.2 (2.4) 
4.0 (3.2) 
5.8(3.1) 
1.3 (0.4) 
1.1 (0.2) 
1.1(0.2) 
1.2(0.3) 
1.0(0.3) 
1.0(0.3) 
11.2(6.6) 
9.6(3.5) 
9.2 (4.7) 
57.0 (9.4) 
60.2 (8.0) 
61.2(8.9) 
109.0 (24.6) 
117.8(18.9) 
116.2(22.7) 
UPDRS, Unified Parkinson's Disease Rating Scale 
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m Pre-test 
D Post-test 
£3 Washout 
PD SAFEx Non-SAFE 
Figure 1 - Unified Parkinson's Disease Rating Scale (UPDRS) scores at pre-test, post-
test, and washout for the two exercise groups. * denotes significance at p<.05. 
SAFE, Sensory Attention Focused Exercise 
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Figure 2a - Main effect of time for the affected side related changes on the Unified 
Parkinson's Disease Rating Scale (UPDRS). Significant main effect at p<.001, post-test 
was significantly less severe than pre-test and washout. 
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Figure 2b - Main effect of time for the non-affected side related changes on the Unified 
Parkinson's Disease Rating Scale (UPDRS). Significant main effect at p<.01, post-test 
was significantly less severe than pre-test and washout. 
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Figure 3a - Main effect of the rate (sec/peg) for the remove phase of the grooved 
pegboard for the affected side. Significant main effect at p<01, post-test and washout 
were significantly faster than pre-test. 
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Figure 3b - Main effect of the rate (sec/peg) for the remove phase of the grooved 
pegboard for the non-affected side. Significant main effect at p<.001, post-test and 
washout were significantly faster than pre-test. 
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Figure 4 - Main effect of time for the Timed-Up-and-Go (TUG). Significant main effect 
at p<.01, post-test and washout were significantly faster than pre-test. 
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CHAPTER 5 
VERIFYING THE EFFECTIVENESS & REPLICABILITY OF THE SENSORY 
ATTENTION FOCUSED EXERCISE INTERVENTION 
ABSTRACT 
There were two main aims of the current study. The first was to determine 
whether a sensory attention focused exercise (PD SAFEX) intervention would result in 
consistent symptomatic improvements across multiple administrations. The second was 
to determine if the intervention could be replicated when administered by minimally 
trained individuals in the community. The PD SAFEX intervention was administered six 
times; four at the Movement Disorders Research and Rehabilitation Centre (MDRC); two 
at an exercise facility in Oakville, ON (YMCA). Results demonstrated that regardless of 
the administration group, similar percent change on symptomatic assessment (UPDRS), 
indicating improved symptoms, was observed. Interestingly, the intervention at the 
YMCA resulted in significantly greater symptom percent improvement than the MDRC 
led PD SAFEX intervention. The results demonstrate that the PD SAFEX intervention 
consistently provides symptomatic benefit and is likely to continue to display benefits if 
globally implemented. The replicability of the findings from the PD SAFEX intervention 
are particularly promising as rarely has an exercise intervention been shown to reliably 
change the symptoms of a disease like Parkinson's. The minimal training and equipment 
needed to implement the PD SAFEX intervention indicate that future directions should 
consider widespread distribution of the PD SAFEX exercise descriptions and evaluate the 
effect of the exercise in multiple settings and the home environment. 
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INTRODUCTION 
Currently, no scientifically based exercise recommendations exist for individuals 
with Parkinson's disease (PD) (de Goede, Keus, Kwakkel, & Wagenaar, 2001; Deane et 
al., 2002). One of the issues clouding the search for the optimal exercise strategy is the 
difficulty of designing experiments that are capable of accurately comparing exercise 
strategies. Often, similar exercise programs such as body-weight supported treadmill 
training (BWSTT) (Miyai et al., 2000; Miyai et al., 2002), regular treadmill training 
(Cakit, Saracoglu, Gene, Erdem, & Inan, 2007), and outdoor walking training (Lokk, 
2000; Sunvisson, Lokk, Ericson, Winblad, & Ekman, 1997) cannot be compared due to 
differing training lengths, and outcome measures used. 
An additional challenge is that few rehabilitation studies have attempted to 
demonstrate that the identified effectiveness of an exercise strategy is replicable over 
multiple administrations. This is especially concerning when small sample sizes (N<10) 
are used, which can leave findings susceptible to chance. For example, Miyai et al. found 
conflicting results while examining body-weight supported treadmill training (BWSTT) 
in two different samples often participants with PD (Miyai et al., 2000; Miyai et al., 
2002). The first project found that BWSTT resulted in improved PD symptoms measured 
using the Unified Parkinson's Disease Rating Scale (UPDRS) (Miyai et al., 2000), while 
the second project did not find a significant effect of training on PD symptoms (Miyai et 
al., 2002). While no suggestion was provided to explain the discrepancy between the 
symptomatic results, perhaps, the small samples (n=10 & 11) allowed day to day 
fluctuations in PD symptoms to have undue influence on the results, suggesting that 
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findings should be replicated with increasing sample sizes to effectively evaluate an 
exercise intervention. 
Conversely, del Olmo et al. found similar effects in two groups of individuals 
with PD following four weeks of gait exercises that were paced with a metronome (del 
Olmo, Arias, Furio, Pozo, & Cudeiro, 2006; del Olmo & Cudeiro, 2005). The first group 
of 15 PD participants displayed a decreased coefficient of variation (a measure of 
temporal variability of gait) following exercise (del Olmo & Cudeiro, 2005). The second 
group of nine PD participants replicated these findings and also used positron emission 
tomography (PET) to suggest that the coefficient of variation improvements were likely 
the result of improved neural function (del Olmo et al., 2006). Clearly, replication of 
exercise rehabilitation interventions is important to ensure any improvements are not due 
to chance but the true result of a therapeutic intervention. To approve new drug 
treatments for PD several studies to replicate the effectiveness are required, as witnessed 
by the newest drug rasagaline, which underwent repeated evaluation before it could be 
recommended and approved for use in North America (Pahwa et al., 2006; Rascol et al., 
2005). For an exercise to be accepted as an effective adjunct therapy for use in a clinical 
population such as PD it should be subjected to the same rigorous testing as new 
medications. 
Of further importance is the feasibility for a PD exercise intervention to be 
globally utilized. To be truly beneficial to the PD community the exercise intervention 
must be easy to follow, simple and cost-effective to implement. Thus, while BWSTT or 
resistance training may prove to be beneficial for individuals with PD, it may be 
unrealistic to expect that all PD patients will be able to gain access to the specialized 
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equipment and appropriately trained experts to deliver such an intervention. As such, the 
current study utilized minimal equipment (a standard office chair and latex Thera-
bands®) and a group setting (less instructors required for more exercise participants) to 
deliver an exercise intervention that was cost-effective and could be easily and effectively 
administered to a large number of individuals with PD and that might be easily 
transferred to the patient's home environment. 
The current study had two main purposes. The first was to determine whether 
improved PD symptoms following a sensory attention focused exercise (PD SAFEX) 
intervention could be replicated across multiple administrations. The PD SAFEX program 
was administered from September 2006 to December 2007, representing four twelve 
week exercise sessions (fall 2006, winter, summer and fall 2007). In addition to the four 
PD SAFEX sessions at the MDRC, the program was administered twice at a YMCA in 
Oakville, ON from January to August 2007. As the PD SAFEX program was a new 
intervention utilizing minimal equipment and a cost-effective group setting it was crucial 
to determine if the exercise program could be effectively administered by members of the 
community to assess the feasibility of global implementation of the program. Thus, the 
second aim was to determine if the effect of the intervention could be replicated when 
administered by the researchers (MDRC) or by minimally trained individuals in the 
community (YMCA). It was hypothesized that PD SAFEX would result in consistent 
symptomatic improvement across the administrations and that the MDRC and YMCA 
would display similar improvements following exercise. 
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METHODS 
Participants 
Thirty-nine participants (F-12, M-27, mean age=67.4, SD=9.8) were enrolled in 
the current study from the patient database at the Movement Disorders Research and 
Rehabilitation Centre (MDRC), Wilfrid Laurier University. The participants represent a 
small portion of a large multi-site exercise rehabilitation study in PD. Participants' 
completed the exercise intervention during the fall of 2006, or the winter, summer or fall 
of 2007. As multiple exercise programs were investigated as part of the larger project and 
participants could have been involved in successive programs, the current study included 
those participants in their first exercise intervention who participated in all testing 
sessions. 
Exercise Intervention 
Each participant was administered a sensory attention focused exercise (PD 
SAFEX) intervention over a ten to twelve week period depending on the season of 
administration (due to the respective holidays associated with the season). The exercise 
intervention was run three times per week (Mon, Wed, and Fri) for approximately one 
hour per session. The first 20-30 minutes was dedicated to PD SAFEX walking exercises 
followed by 20-30 minutes of exercises using a standard office chair with latex Thera-
bands® attached to the arms for resistance (for examples see a previously published 
description (Sage & Almeida, In Press) and appendix A). 
Two sites were used to determine the transferability of the exercise program to a 
community setting. The exercise intervention at the first centre, the MDRC, was 
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administered by one lead instructor and enough volunteers to maintain a 2:1 ratio of 
participants to volunteers. The lead instructor had been educated on movement disorders, 
specifically PD, and was familiar with the reasoning behind the design of the PD SAFEX 
program. Similarly, the volunteers were senior undergraduate kinesiology students that 
received training in the proper administration of the exercise program, and many of the 
volunteers were enrolled in a movement disorders class. The volunteers' primary role 
was to ensure participants completed each exercise properly, fix incorrect positioning and 
remind participants of the sensory cues. The second site, the YMCA in Oakville Ontario, 
had a team of 2-4 leaders who were personal trainers and group exercise leaders at the 
exercise facility. The leaders observed two sessions of the PD SAFEX intervention at the 
MDRC and received written instructions detailing each exercise, as well as a 1 hour 
tutorial on the typical movement impairments they might expect to see with PD 
participants. Open communication between the YMCA leaders and the MDRC was 
available over the duration of the exercise intervention and the YMCA leaders did not 
express any difficulty understanding the written description of the exercises. Participants 
that required assistance to complete the exercises were encouraged to bring a family 
member or personal assistant since volunteers or extra staff might not be unavailable at 
this location. 
The goal of the program was to have participants focus their attention on the 
sensory, primarily proprioceptive, feedback received while completing the exercise 
program. To force participants to focus and rely on proprioceptive feedback, vision was 
dampened [as per (Rose, 2005)] or removed entirely as the exercise facility was darkened 
and participants had their eyes closed for the second set of each exercise. The instructor 
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also keyed participants to specific portions of each exercise and the sensory feedback 
received during proper completion of the exercise. Each week the exercise intervention 
became progressively more challenging as new exercises were added or existing 
exercises were modified. 
Evaluation 
A single evaluator blinded to group assignment assessed each participant before 
the exercise program began (pre-test) and again following the exercise program (post-
test). Blinding was achieved by testing participants from multiple exercise programs and 
non-exercise control participants in a random order on the same day with participants 
instructed not to reveal their group assignment. The primary outcome measure was an 
assessment of PD motor symptoms using the Unified Parkinson's Disease Rating Scale 
(UPDRS). The UPDRS provides a rating of PD symptom severity as each motor 
symptom was rated using a scale of zero to four with zero being an absence of symptoms 
and four representing the most severe symptoms. Thus, a higher UPDRS indicated more 
severe PD symptoms; the maximum score was 108. 
Statistical analysis was completed using Statistica computer software, following 
'intention to treat' principles, and an alpha level set at .05. Any significant findings in 
analysis of variance were followed up using Tukey's post-hoc criteria. The first analysis 
was a time (pre-test vs post-test) by group (MDRC: fall 2006 vs winter 2007 vs summer 
2007 vs fall 2007 vs YMCA: winter 2007 vs summer 2007) analysis of variance. As the 
groups were small and pre-test disease severity was not controlled, a percent change was 
calculated to standardize the improvements regardless of pre-test disease severity. The 
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percent change was calculated as (pre-test - post-test)/pre-test x 100% such that a 
positive percent change indicated an improvement following exercise. A one-way 
ANOVA comparing the percent change for the six exercise administrations was analyzed. 
The second analysis collapsed the exercise groups based on the site of 
administration to determine if a difference existed between the MDRC and YMCA. A 
group (MDRC vs YMCA) by time (pre-test vs post-test) ANOVA and an independent t-
test of the UPDRS percent change were used to compare the groups. 
Finally, an analysis of participants who received the PD SAFEX intervention in 
two consecutive 12-week exercise sessions (separated by a six week non-exercise period) 
was performed to assess the effect of a multiple administrations over a longer period. As 
only five participants had completed the PD SAFEX program in successive time periods 
this analysis was preliminary and exploratory. The scores at pre-test and post-test were 
compared for both the first and second administration of PD SAFEX using a repeated 
measures ANOVA. Additionally, a dependent t-test was employed to compare the 
percent change from the first and second administrations of the PD SAFEX program. 
121 
RESULTS 
Exercise participants at the MDRC and YMCA had comparable ages and disease 
severity levels. The YMCA group had a smaller mean number of years since diagnosis 
(mean=2.4) of PD than the MDRC group (mean=4.8). Table 1 provides a breakdown of 
baseline demographics for the two locations. 
Group Comparisons 
The group by pre-test vs post-test UPDRS score ANOVA revealed a main effect 
of time (F(l,33) = 56.89, p<.001) indicating that post-test disease severity scores were 
significantly lower than pre-test scores. No interaction was identified between the groups 
(F(5,33) = 1.67, p<.169) as all groups improved at post-test compared to pre-test. The 
percent change ANOVA was also non-significant (F(5,33) = 1.79, p<.141) (figure 1). See 
table 2 for a full breakdown of results for each group. 
The MDRC and YMCA comparisons yielded a main effect of time (F(l,37) = 
67.66, p<.001) indicating that disease severity scores were lower at post-test compared to 
pre-test. No interaction effect was identified (F(l,37) = 1.49, p<.23) (figure 2). The 
percent change independent t-test revealed a significant difference between the groups 
(t(37) = 2.11, p<.042), where the YMCA (mean = 39.14, SD = 15.4) had a significantly 
larger percent improvement than MDRC (mean = 25.06, SD = 19.9) (figure 3). 
The first versus second administration of the PD SAFEX program had a trend 
towards a main effect of time (F(l,4) = 6.42, p<.064), with no significant interactions 
identified. Additionally, no difference was found on the percent improvement as the first 
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(mean = 21.1) and second (mean = 22.8) administrations had similar responses to the PD 
SAFEX program. 
DISCUSSION 
The aims of the current study were to determine whether the effectiveness of PD 
SAFEX intervention could be replicated consistently across multiple administrations of 
this novel therapeutic intervention, and specifically whether effectiveness could be 
maintained when delivered in the community (YMCA). Consistent results were observed 
across the four administrations of the PD SAFEX intervention at the MDRC and the two 
administrations at the YMCA. Interestingly, the YMCA run program resulted in a larger 
percent improvement than the MDRC run program. 
A larger percent improvement at the YMCA compared to the MDRC is especially 
interesting because the exercise leaders at the MDRC had more training in movement 
disorders and had more volunteer assistants to ensure participants completed the 
exercises properly. This finding suggests that with minimal training of exercise leaders 
the PD SAFEx intervention could be easily implemented on a large scale and participants 
could expect to receive identical benefits as the samples evaluated in the current study. 
Another strength of the current study was the use of a disease specific measure (UPDRS), 
as this allows the PD specific effect of the exercise to be evaluated. Further, it has been 
suggested that symptoms of disease (as measured with the UPDRS) are not as easily 
influenced by exercise as specific mobility measures such as step length (de Goede et al., 
2001). Thus, the improvement in PD symptoms replicated in multiple administrations of 
the PD SAFEX intervention and across multiple sites suggests with reasonable external 
validity that it is feasible to implement the intervention globally. 
The design of the larger research project into the effect of exercise on PD at the 
MDRC meant that the groups involved in their first administration of the PD SAFEX 
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intervention varied in size and were fairly small. The small groups were a limitation of 
the current study; however, all groups did witness an improvement in UPDRS score 
following exercise. The smallest group of only three participants in the winter of 2007 at 
the MDRC witnessed the smallest percent change of only 7.2% whereas the largest group 
of twelve participants in the fall of 2006 at the MDRC witnessed a substantial percent 
change of 24.7%. Further, the sample of twelve participants is larger than a number of 
commonly referenced PD exercise rehabilitation trials (del Olmo et al., 2006; Marchese, 
Diverio, Zucchi, Lentino, & Abbruzzese, 2000; Miyai et al., 2000; Miyai et al., 2002). As 
such, the small sample sizes, while not as large as desired, were sufficient as the results 
were observed consistently across the groups. 
Only five participants had completed the PD SAFEX intervention during 
consecutive exercise sessions (with a six week non-exercise period in between) as 
participants were randomly assigned to the different exercise programs as part of the 
larger research project. Thus, the comparison of the effect of the first and second 
administrations of the PD SAFEX intervention should only be considered preliminary. 
Nevertheless, during both the first and second exercise sessions the group improved their 
UPDRS scores by 21.1 and 22.8% respectively. It may have been expected that 
participants would receive an additional benefit of the PD SAFEX intervention during the 
second administration as they did not need to learn each exercise. This was not observed 
in the current sample; however, when the sample size is increased a more adequate 
comparison can be made about the effects of the PD SAFEX intervention over a longer 
period of time. 
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Rarely has it been demonstrated that an exercise intervention can reliably change 
the symptoms of a disease like Parkinson's. The results of the current study demonstrate 
that PD symptomatic improvements are reproducible with the use of the PD SAFEX 
intervention, thus providing evidence that suggests that exercise focused on sensory 
feedback is beneficial and the results were not simply due to chance. Additionally, the PD 
SAFEX program requires minimal equipment and training for exercise leaders, as 
supported by the observed improvements in the YMCA groups, which is ideal to 
implement the exercise intervention on a wider scale. One limitation of the current study 
was a lack of quality control to ensure that the YMCA exercise leaders were properly 
administering the PD SAFEX intervention. While the YMCA leaders may not have 
properly instructed some of the minor details of the program, they certainly ensured 
participants exercised with their eyes closed. Having the eyes closed while exercising 
was the most important aspect of the PD SAFEX program as it forces participants to rely 
on proprioceptive and not visual feedback. The results of the current study suggest that 
this aim can be easily implemented by community exercise leaders, although future work 
should evaluate the exercise leaders to ensure consistent instructions are provided to 
participants. 
Future research should distribute the exercise intervention across multiple sites in 
Canada to determine the effectiveness of the PD SAFEX intervention based on a 
simplified manual providing a description of the program to the exercise leaders. An 
additional important direction would be to evaluate the effectiveness of the intervention 
when completed in the home environment to increase the number of individuals able to 
benefit from the novel PD SAFEX intervention. 
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Table 1 - Mean (±standard deviation) of participant demographics at baseline for the 
MDRC and YMCA. 
Group 
MDRC 
YMCA 
Total 
Gender 
F-9.M-19 
F-3, M-8 
F-12, M-27 
Age 
68.3(10.6) 
65.3 (7.5) 
67.4 (9.8) 
Years Since 
Diagnosis 
4.8 (4.3) 
2.4(1.4) 
4.1 (3.9) 
UPDRS 
28.2(10.3) 
25.3 (9.6) 
27.4(10.0) 
UPDRS, Unified Parkinson's disease rating scale; MDRC, Movement Disorders 
Research and Rehabilitation Centre. 
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Table 2 - Mean (±standard deviation) of UPDRS scores and percent change for the six 
groups. Percent change calculated using: (pre-test - post-test)/pre-test x 100% 
Group 
MDRCI 
MDRCII 
MDRC III 
MDRC IV 
YMCAI 
YMCAII 
n 
12 
3 
5 
8 
4 
7 
Pre-test 
27.4(10.8) 
27.5 (8.5) 
20.2 (4.1) 
34.6 (9.9) 
29.5 (12.3) 
23.0(7.8) 
Post-test 
21.0(10.5) 
25.0 (5.4) 
14.7(6.1) 
20.4(11.0) 
13.0(5.4) 
19.5 (8.9) 
Percent Change 
24.7 (20.9) 
7.2(13.1) 
27.4 (28.0) 
30.8(12.8) 
32.2(14.5) 
43.1 (15.5) 
UPDRS, Unified Parkinson's disease rating scale; MDRC, Movement Disorders 
Research and Rehabilitation Centre 
MDRCI MDRCII MDRC III MDRCIV YMCAI YMCAII 
Figure 1 - UPDRS percent change following exercise in the six groups. Note that no 
significant difference was found between the groups. 
UPDRS, Unified Parkinson's disease Rating Scale; MDRC, Movement Disorders 
Research and Rehabilitation Centre 
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Figure 2 - UPDRS score changes following exercise for the two exercise locations. Note 
that the main effect of time (pre-test vs post-test) was significant (p<.001) but is not 
marked. 
UPDRS, Unified Parkinson's disease Rating Scale; MDRC, Movement Disorder 
Research and Rehabilitation Centre 
60 
c 
<D 
E 0) 
> 
p L . 
a. 
E 
^ 
to
rn
 
a 
E 
> 
w 
50 
40 
30 
20 
10 
o+-
MDRC YMCA 
Figure 3 - UPDRS percent change for the two exercise locations. Significant at p<.05. 
Percent change, [(pre-test - post-test)/pre-test x 100%]; UPDRS, Unified Parkinson's 
disease Rating Scale; MDRC, Movement Disorder Research and Rehabilitation Centre 
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CHAPTER 6 
GENERAL DISCUSSION 
The overall objective of the current thesis was to compare various exercise 
interventions to determine the most advantageous strategy for individuals with 
Parkinson's disease (PD). To achieve this aim chapter two investigated the ability of 
objective outcome measures to reflect symptomatic assessment using the Unified 
Parkinson's Disease Rating Scale (UPDRS). Chapter three compared four exercise 
programs, representing a spectrum of traditional exercise strategies and a sensory 
feedback based strategy, with a non-exercise control group to determine which exercise 
strategies had the greatest beneficial effect on PD motor symptoms. Chapter four 
investigated the role of increased focus on sensory (specifically proprioceptive) feedback 
in an exercise program through a comparison between a sensory attention focused 
exercise (PD SAFEX) program and an identical program differing only on the absence of 
focus on sensory feedback. Finally, chapter five assessed the ability of the PD SAFEX 
program to be administered in the community by comparing multiple administrations of 
the PD SAFEX program run by the researcher and community instructors who received 
minimal training in the proper administration of the exercises. 
Objective measures that reflect PD symptoms 
While symptom management would be the primary goal for any therapeutic 
intervention, minimal investigation has been done to determine what objective measures 
are best able to reflect the classical symptoms of PD. Chapter two tackled this important 
question by assessing which objective measures were the best predictors of PD symptoms 
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(measured using the Unified Parkinson's Disease Rating Scale (UPDRS)). Additionally, 
the ability of objective measures to reflect symptomatic changes resulting from exercise 
was also evaluated. The results suggested that the grooved pegboard (GP), specifically 
the place phase, was the best measure to predict symptomatic assessment. Interestingly, 
none of the objective measures had a significant relationship with the symptom changes 
(measured as subsets of the UPDRS), they were hypothesized to be evaluating. 
Unfortunately, the current thesis only identified the grooved pegboard (GP) as an 
effective predictor of PD symptoms. Even then, the best predictor, the GP place phase 
only accounted for less than 30% of the variability in UPDRS score, leaving over 70% 
unaccounted for. Thus, the search for effective objective measures has just begun. 
Functional measures such as the timed-up-and-go should continue to be investigated as 
they may be evaluating symptomatic deficits identified through the UPDRS. 
Additionally, functional measures, although not seen to be reflective of symptomatic 
changes in the current thesis, may reveal the ability of an individual to function in their 
home environment. Overall, the results of the current thesis suggest that other objective 
measures should be investigated for their ability to reflect symptomatic assessment. 
While numerous potentially beneficial objective measures exist, a few intriguing 
directions to build on the current study are movement variability and muscle activation 
patterns. Movement variability especially during gait has been suggested to be attributed 
to abnormal internal cues being sent from the basal ganglia to guide sequential 
movements (del Olmo & Cudeiro, 2005). One estimate of movement variability is the 
coefficient of variation (standard deviation/mean) x 100), which standardizes variability 
to the mean (Almeida, Frank, Roy, Patla, & Jog, 2007). Interestingly, del Olmo et al. 
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have found significant improvements in the coefficient of variation for step length and 
finger tapping following gait exercises rhythmically paced by a metronome (del Olmo, 
Arias, Furio, Pozo, & Cudeiro, 2006; del Olmo & Cudeiro, 2005). Similarly, muscle 
activation patterns may be hindered due to the disrupted basal ganglia in PD. Thaut et al. 
observed improvements in muscle activation of the lower leg towards a more normalized 
activation pattern following gait exercises paced externally by a metronome (Thaut et al., 
1996). Since movement variability and muscle activation have been suggested to be 
reflective of the functioning level of the basal ganglia measures of these movement 
aspects may also be reflective of PD symptoms. A logical future direction would be to 
assess the ability of these and other novel measures to reflect symptomatic assessment of 
PD. 
While the current thesis only identified the GP as a significant predictor of 
symptomatic assessment, future exploration in this area is necessary. Determining which 
objective measures are most reflective of symptomatic assessment in PD would greatly 
benefit researchers evaluating exercise techniques. Outcome measures could be 
standardized for future trials and previous literature could be effectively scrutinized to 
determine its symptomatic effect. Currently, however, symptomatic measures such as the 
UPDRS should accompany objective measures to ensure changes observed are disease 
relevant and not simply general musculoskeletal or cardiovascular benefits that any 
individual would expect to receive from the exercise. 
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Which exercise technique is best? 
Chapter three aimed to determine the most beneficial exercise strategy for 
individuals with PD by improving on previous shortfalls including inconsistent length of 
exercise interventions, inconsistent use of PD symptomatic measures, absence of a non-
exercise follow-up assessment and lack of a placebo/control group. Three exercise 
programs based on traditional exercise strategies including aquatic exercise, aerobic 
training and strength training were compared to a novel exercise strategy, sensory 
attention focused exercise (PD SAFEX), and a non-exercise control group. All participants 
exercised three times a week for twelve weeks and were symptomatically assessed using 
the Unified Parkinson's Disease Rating Scale (UPDRS). Overall, the strength training 
and PD SAFEX programs were seen to have the greatest symptomatic improvement 
following exercise. 
While the PD symptomatic evaluation using the UPDRS provided an adequate 
comparison between the exercise strategies a detailed evaluation between the strength 
training and PD SAFEX programs is warranted to evaluate if the symptomatic 
improvements witnessed are the result of improved neurological functioning or 
musculoskeletal fitness. The UPDRS is the current gold standard of PD symptom 
assessment; however a number of items may be unduly influenced by strength gains. For 
example, items such as sit-to-stand, posture and postural stability may be improved due 
to musculoskeletal strengthening. The PD SAFEx program was not focused on aerobic or 
strength gains; rather the focus was improved body awareness and coordination. Thus, 
the improved symptoms in the PD S AFEX group may be due to improved movement 
control (neurological functioning) while the improvements in the strength training group 
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may be influenced by improved musculoskeletal strength. The current thesis, however, 
cannot adequately evaluate whether the benefits from the two exercise programs are the 
result of improved neurological function or increased muscle strength, and future work 
should include an in depth analysis of the two programs to address this important area. 
A number of important factors were controlled in the current evaluation of 
exercise techniques such as identical exercise lengths, PD symptomatic assessment, and 
the comparison with a non-exercise control group. Thus, the methodological quality of 
the current thesis suggests that strength training and PD SAFEX have the greatest 
symptomatic benefit for individuals with PD. 
The role of increased focus on sensory feedback in exercise 
The influence of increased focus on sensory feedback (specifically 
proprioception) in an exercise setting has never been evaluated in PD. Thus, a 
comparison of two programs that differed only in the presence or absence of increased 
sensory attention (permitting the isolation of this single variable) was undertaken. The 
results of this study were strengthened by the fact that both programs were administered 
by the same individual in a single facility. Thus, the only difference between the 
programs was the focus on sensory feedback. Interestingly, both programs benefited on a 
number of measures (timed-up-and-go, grooved pegboard remove phase, and step length) 
but only the sensory attention focused exercise (PD SAFEX) program had improved PD 
symptoms displaying the additive benefit of increased focus of attention on sensory 
feedback. 
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The difference between the exercise programs was only evident on the 
symptomatic assessment of PD symptoms. However, this is of increased importance as 
the goal of any exercise intervention in PD should be to improve symptoms. 
Additionally, this points to the importance of including symptomatic assessment in 
exercise rehabilitation trials to ensure changes are disease relevant. Without a 
symptomatic evaluation the current study may have concluded that increased sensory 
feedback does not provide additional benefit. This suggests that previous exercise trials in 
PD without a symptomatic evaluation do not provide a complete picture and may be 
concluding success based on general musculoskeletal, cardio respiratory or mobility 
benefits rather than PD relevant symptomatic improvement. Any therapeutic intervention 
(drug, exercise or alternative therapy) should combine symptom measures and also other 
objective functional outcome measures to evaluate the functional and symptomatic 
benefit of the therapy in question. 
The current results do suggest that focused attention on sensory feedback is an 
effective addition to PD exercise rehabilitation. Achieving increased focus on sensory 
feedback was relatively simple to integrate as this was achieved in the current program by 
having participants close their eyes, thus the potential application to other settings would 
be a logical area to explore. 
Replicability of the PD SAFEx intervention 
Chapter five attempted to verify whether the effectiveness of the PD SAFEX 
intervention could be replicated across multiple administrations. This was an important 
consideration, since exercise interventions are rarely scrutinized to the same degree that 
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pharmaceuticals are before treatments are approved. For example, Miyai et al. assessed 
body-weight supported treadmill training in two separate groups and while the first group 
revealed symptomatic benefit, the second did not (Miyai et al, 2000; Miyai et al , 2002). 
The results of the current study revealed that the symptomatic improvements were 
replicable as improved PD symptoms were found following four administrations of the 
PD SAFEX intervention at the Movement Disorders Research and Rehabilitation Centre 
(MDRC) and two administrations of the PD SAFEX program at an exercise facility in the 
community (YMCA). 
Of further interest was the ability of the PD SAFEX program to be implemented in 
a community setting with minimal training of exercise leaders. Interestingly, the PD 
SAFEX program implemented by the researcher (MDRC) had a significantly lower 
percent improvement following exercise than the PD SAFEX program led by individuals 
in the community (YMCA). This finding was unexpected as it was thought that 
knowledge of the underlying neurological deficits in PD that were the focused in the PD 
SAFEX program would lead to more accurate exercise descriptions. While the sample size 
(n = 11) of the YMCA group was fairly small, the results point to the ease of 
administration of the PD SAFEX program and the suitability of the exercise intervention 
for the general PD population. The main goal of the PD SAFEX program was to increase 
focus on sensory (specifically proprioceptive) feedback and was mainly achieved by 
having participants complete the exercises with their eyes closed. Thus, while the YMCA 
exercise leaders may not have achieved all the smaller aims of the PD SAFEX program, 
they would have ensured participants kept their eyes closed and this may be enough to 
increase attention on sensory feedback. 
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The external validity of the PD SAFEX program is excellent as the symptomatic 
results were found over multiple administrations and under different exercise leaders. As 
the PD SAFEX program was effectively administered by individuals receiving little 
training a logical progression would be to evaluate the PD SAFEX program in the home 
environment. As mobility becomes more difficult as disease severity increases the 
simplicity of the PD SAFEX program may be ideal to apply in an individual's home. 
Conclusion 
Improving upon numerous shortfalls in previous research such as inconsistent use 
of symptomatic measures, differing lengths of intervention, lack of an adequate control 
group and absence of assessment following a non-exercise washout period, the most 
effective exercise rehabilitation interventions revealed by the current thesis were strength 
training and sensory attention focused exercise (PD SAFEX). Further evaluation of the PD 
SAFEX program revealed that increased focus on sensory feedback was easy to 
implement and reliably provided symptomatic improvements. Thus, increased focus on 
sensory feedback appears to be a simple, effective strategy that improves PD symptoms 
and likely leads to improved neurological functioning of the basal ganglia, the central 
deficit of PD. Future research should continue to evaluate the long term delivery of PD 
SAFEX; increase the sample size; continue to search for better objective measures; and 
evaluate PD SAFEX in the home environment after providing minimal instruction. 
Additionally, future work should attempt to combine benefits gained from aerobic 
training, strength training and PD SAFEX since increased strength and cardiovascular 
health may also be important to combat secondary deficits associated with PD. 
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Future Recommendations 
The PD S AFEX and strength training programs had the greatest positive influence 
on PD symptoms. Specifically, the PD SAFEX program requires minimal equipment and 
appears to be easy to implement in the community environment. However, it will be 
important to address several important areas to confirm the effectiveness and delivery of 
this program. 
• Assess effects of exercise across wide range of disease severities. 
• Combine the exercise interventions such as strength training and PD SAFEX to 
maximize benefits. 
• Detailed comparison of strength training and PD S AFEX to determine if 
symptomatic improvements are the result of neural or musculoskeletal changes. 
• Increase sample size to address loss of participants, especially at washout testing. 
• Determine if individuals who receive a greater benefit of exercise also have a 
greater lasting benefit (compared to individuals who do not receive a large benefit 
of exercise). 
• Administer the PD SAFEX intervention at numerous sites and evaluate the 
instructors to ensure exercises are identical at all sites. 
• Investigate longer exercise periods such as 24 weeks or one year, especially for 
the PD SAFEX program. Compare longer administrations of PD SAFEX with non-
exercise control participants to compare progression of PD symptoms. 
• Evaluate the PD SAFEX program in the home environment with minimal 
instruction to determine its effectiveness for individuals with limited mobility. 
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APPENDIX A 
DESCRIPTION OF THE SENSORY ATTENTION FOCUSED EXERCISE (PD 
SAFEX) INTERVENTION 
From: 
Sage, M.D., & Almeida, Q.J. (In Press). Symptom and gait changes after sensory 
attention focused exercise vs aerobic training in Parkinson's. Mov Disord. 
Description of Sensory Attention Focused Exercise (PD SAFEX) program 
The goal of the PD SAFEX program was to focus patient's attention on sensory feedback 
during movement (specifically proprioceptive feedback). This was accomplished using 
exercises that would challenge coordination, body awareness and balance while cueing 
participants' to specific sensory feedback from each exercise. Exercises were done in a 
group setting, 1 instructor and 6-8 student volunteers for approximately 1 hour. Exercise 
sessions were completed with lights dimmed and eyes closed for most sets of exercise. 
The exercises became progressively more difficult each week by increasing the 
coordination demands on the participants. 
Gait Exercises (20-30 min) 
A 37.5 meter hallway at the Movement Disorders Research & Rehabilitation Centre, 
Wilfrid Laurier University) was traversed twice to make a 75 meter circuit used for many 
of the exercises. Student volunteers were placed along the middle of the hallway to 
reinforce instructions, ensure participants completed exercises properly and remind 
participants of the specific sensory feedback to focus on for each exercise. 
General instructions for all gait exercises: 
1. Go Slowly - Participants walked at a slow pace to ensure they completed each 
exercise properly and this allowed participants time to interpret the proper sensory 
feedback cues (without any specific focus on improving aerobic capacity). 
2. Keep eyes closed - The first time a new exercise was introduced, participants 
completed the circuit with eyes open. In subsequent repetitions, participants were 
instructed to keep eyes closed for longer periods of time, i.e. keep eyes closed for 
two steps, open for one. After 2 rounds of the exercise participants kept eyes 
closed for the entire circuit. 
Specific examples from PD SAFEX program 
Weekl 
Week 6 
EXERCISE 
Opposite arm and leg move together 
with aim of bringing the hand up to the 
cheek, while opposite knee was raised 
up until thigh was parallel to ground. 
E.g. right hand comes up to ear and left 
knee is raised. 
Holding shirt at the shoulders with 
upright correct posture, bring the knee 
SENSORY ATTENTION 
FOCUS 
i) Limb coordination pattern is 
same as during gait 
ii) Hand and cheek contact sends 
tactile feedback 
iii) Upright posture reinforced 
i) Twist challenges balance and 
coordination 
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Week 12 
up and across the body while twisting 
the torso to have the elbow and knee 
contact; do not bend at the waist to 
bring the elbow down to the knee. 
Alternate between 10 steps heel-toe 
walking ensuring the heel and toe touch 
every step. Then 5 'Stomp' Lunges: 
step forward as large as possible, and 
stomp the front foot into the ground by 
landing on the heel and 'slapping' toes 
on the floor). Bring rear knee down to 
contact the floor and then back up. 
ii) Knee and elbow contact 
provides feedback to confirm 
limb position 
iii) Upright posture reinforced 
i) Heel-toe contact provides 
tactile feedback to confirm feet 
position 
ii) 'Stomp' increases sensory 
feedback sent to the CNS 
iii) As knee touches floor, 
participants confirm they are 
completing exercise properly 
Sensory Attention (Chair/Room) Exercises (20-30 min.) 
Equipment used for this portion of the exercises included a standard office chair with arm 
rests and two latex Thera-bands®. The aim was not strength or aerobic training and the 
Thera-bands® were used to provide minimal resistance when completing certain upper 
limb exercises. 
General Instructions for Exercises: 
1. Sensory Reminders - Instructor's description of exercises focused on key 
portions for participants to focus on. Volunteers also reminded participants 
what to focus on while completing exercises. 
2. Lights Off, eyes closed - Lights were turned off in exercise room and second 
set of each exercise was done with eyes closed. This forced participants to rely 
on prioproceptive and not visual information to ensure limbs were in the 
correct position. 
Specific examples from PD SAFEX program 
Weekl 
Week 6 
EXERCISE 
Both hands on the back chair legs, back 
against chair and chest pointing out. Slide 
right hand down right chair leg, while 
sliding left hand up left chair leg; hold, 
then switch sides and repeat. 
Alternating bicep curls in continuous 
motion. E.g. as right arm curls, left arm 
simultaneously relaxes. 
Standing toe circles using the back of the 
chair for support. Trace a large circle on 
the floor with the big toe. Supporting leg 
bends at the knee to allow a larger circle 
to be traced. 
SENSORY ATTENTION 
FOCUS 
i) Hands on chair legs, and 
stretch through torso 
ii) 2nd set confirm that stretch 
is the same as 1st, using only 
the above sensory feedback 
iii) Upright posture reinforced 
i) Hand & shoulder contact, 
providing sensory feedback to 
indicate end of curl 
ii) Opposite motion of upper 
limbs challenges coordination 
i) Tactile feedback from the 
toe tracing circle 
ii) Balance challenge for 
supporting leg 
iii) Upright posture reinforced 
146 
Week 12 
Pretend arms are the arms of a clock and 
move to time chosen by instructor while 
holding Thera-bands® with palms facing 
the floor. 
Imagine holding a basketball with both 
hands. While inhaling, roll ball in front, 
bending at the waist. From here, move the 
hands to encircle the left side of the ball. 
While exhaling, roll ball to the right. 
Reach around the far side of the ball and, 
while inhaling, roll the ball into the chest. 
Exhale while holding ball at chest. 
Repeat, rolling the ball to the left. 
i) Difficult coordination 
ii) Participants ensure proper 
limb position based on 
proprioceptive feedback 
i) Difficult coordination of 
limbs, hands, torso & 
breathing 
ii) Utilize proprioceptive 
feedback to position hand 
correctly to "rolf ball in 
desired direction 
iii) Upright posture reinforced 
